FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kang, SJ
   Tanaka, T
   Inoue, H
   Ono, C
   Hashimoto, S
   Kioi, Y
   Matsumoto, H
   Matsuura, H
   Matsubara, T
   Shimizu, K
   Ogura, H
   Matsuura, Y
   Kishimoto, T
AF Kang, Sujin
   Tanaka, Toshio
   Inoue, Hitomi
   Ono, Chikako
   Hashimoto, Shoji
   Kioi, Yoshiyuki
   Matsumoto, Hisatake
   Matsuura, Hiroshi
   Matsubara, Tsunehiro
   Shimizu, Kentaro
   Ogura, Hiroshi
   Matsuura, Yoshiharu
   Kishimoto, Tadamitsu
TI IL-6 trans-signaling induces plasminogen activator inhibitor-1 from
   vascular endothelial cells in cytokine release syndrome
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE interleukin-6; tocilizumab; ECs/HPMECs/HUVECs/MPVECs; cytokine release syndrome; COVID-19/SARS-CoV-2/Coronavirus 
ID INFLAMMATORY RESPONSE; RECEPTOR; INTERLEUKIN-6; SEPSIS; MARKER; SERUM
AB Cytokine release syndrome (CRS) is a life-threatening complication induced by systemic inflammatory responses to infections, including bacteria and chimeric antigen receptor T cell therapy. There are currently no immunotherapies with proven clinical efficacy and understanding of the molecular mechanisms of CRS pathogenesis is limited. Here, we found that patients diagnosed with CRS from sepsis, acute respiratory distress syndrome (ARDS), or burns showed common manifestations: strikingly elevated levels of the four proinflammatory cytokines interleukin (IL)-6, IL-8, monocyte chemotactic protein-1 (MCP-1), and IL-10 and the coagulation cascade activator plasminogen activator inhibitor-1 (PAI-1). Our in vitro data indicate that endothelial IL-6 trans-signaling formed an inflammation circuit for robust IL-6, IL-8, and MCP-1 production and promoted PAI-1 production; additionally, an IL-6 signaling blockade by the human monoclonal antibody tocilizumab blunted endothelial cell activation. Plasma from severe COVID-19 patients similarly exhibited increased IL-6, IL-10, and MCP-1 levels, but these levels were not as high as those in patients with CRS from other causes. In contrast, the PAI-1 levels in COVID-19 patients were as highly elevated as those in patients with bacterial sepsis or ARDS. Tocilizumab treatment decreased the PAI-1 levels and alleviated critical illness in severe COVID-19 patients. Our findings suggest that distinct levels of cytokine production are associated with CRS induced by bacterial infection and COVID-19, but both CRS types are accompanied by endotheliopathy through IL-6 trans-signaling. Thus, the present study highlights the crucial role of IL-6 signaling in endothelial dysfunction during bacterial infection and COVID-19.
C1 [Kang, Sujin; Inoue, Hitomi; Kioi, Yoshiyuki; Kishimoto, Tadamitsu] Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, Suita, Osaka 5650871, Japan.
   [Tanaka, Toshio] Osaka Habikino Med Ctr, Med Affairs Bur, Osaka 5838588, Japan.
   [Ono, Chikako; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Suita, Osaka 5650871, Japan.
   [Hashimoto, Shoji] Osaka Habikino Med Ctr, Dept Clin Lab, Osaka 5838588, Japan.
   [Matsumoto, Hisatake; Matsuura, Hiroshi; Matsubara, Tsunehiro; Shimizu, Kentaro; Ogura, Hiroshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
C3 Osaka University; Osaka University; Osaka University
RP Kishimoto, T (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, Suita, Osaka 5650871, Japan.
EM kishimoto@ifrec.osaka-u.ac.jp
OI Matsubara, Tsunehiro/0000-0002-0910-3124; Matsumoto,
   Hisatake/0000-0001-5771-570X
FU Ono Medical Research Foundation; Takeda Science Foundation; Kishimoto
   Foundation
FX We thank M. Okawa for secretarial assistance and Mitchell Arico, Melissa
   Crawford, PhD, and Katie Oakley, PhD, from Edanz Group for editing a
   draft of this manuscript. We thank A. Osuka (Japan Community Health Care
   Organization Chukyo Hospital) for providing the sera of patients with
   burns. This work was supported by research grants from the Ono Medical
   Research Foundation (to S.K.), Takeda Science Foundation (to S.K.), and
   Kishimoto Foundation.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC
   Esmon CT, 1999, HAEMATOLOGICA, V84, P254
   Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368
   Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026
   Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5
   Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181
   Matsumoto H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32275-8
   Matsuura H, 2019, SHOCK, V51, P185, DOI 10.1097/SHK.0000000000001152
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846
   Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4
   Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872
   PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459
   Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290
   Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9
   Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782
   Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327
   Teachey DT, 2013, BLOOD, V121, P5154, DOI 10.1182/blood-2013-02-485623
   Terpstra ML, 2014, CRIT CARE MED, V42, P691, DOI 10.1097/01.ccm.0000435669.60811.24
   van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333
   Wang ZG, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0116-0
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Zegeye MM, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0268-4
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 32
TC 156
Z9 163
U1 8
U2 39
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 8
PY 2020
VL 117
IS 36
BP 22351
EP 22356
DI 10.1073/pnas.2010229117
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NT5GH
UT WOS:000572968600006
PM 32826331
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Acosta, MAT
   Singer, BD
AF Acosta, Manuel A. Torres
   Singer, Benjamin D.
TI Pathogenesis of COVID-19-induced ARDS: implications for an ageing
   population
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID MACROPHAGE ACTIVATION SYNDROME; RESPIRATORY-DISTRESS-SYNDROME;
   REGULATORY T-CELLS; INFLUENZA-VIRUS; LUNG INJURY; IN-VIVO; INTERFERON;
   INFECTION; CORONAVIRUS; SARS-COV-2
AB The coronavirus disease 2019 (COVID-19) pandemic has elicited a swift response by the scientific community to elucidate the pathogenesis of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-induced lung injury and develop effective therapeutics. Clinical data indicate that severe COVID-19 most commonly manifests as viral pneumonia-induced acute respiratory distress syndrome (ARDS), a clinical entity mechanistically understood best in the context of influenza A virus-induced pneumonia. Similar to influenza, advanced age has emerged as the leading host risk factor for developing severe COVID-19. In this review we connect the current understanding of the SARS-CoV-2 replication cycle and host response to the clinical presentation of COVID-19, borrowing concepts from influenza A virus-induced ARDS pathogenesis and discussing how these ideas inform our evolving understanding of COVID-19-induced ARDS. We also consider important differences between COVID-19 and influenza, mainly the protean clinical presentation and associated lymphopenia of COVID-19, the contrasting role of interferon-gamma in mediating the host immune response to these viruses, and the tropism for vascular endothelial cells of SARS-CoV-2, commenting on the potential limitations of influenza as a model for COVID-19. Finally, we explore hallmarks of ageing that could explain the association between advanced age and susceptibility to severe COVID-19.
C1 [Acosta, Manuel A. Torres; Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611, United States.
   [Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611, United States.
   [Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611, United States.
C3 Northwestern University; Feinberg School of Medicine; Northwestern
   University; Feinberg School of Medicine; Northwestern University;
   Feinberg School of Medicine
RP Singer, BD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med,Simpson Querrey Ctr Epigenet, Div Pulm & Crit Care Med,Dept Biochem & Mol Genet, Simpson Querrey,5th Floor, Chicago, IL 60611 USA.
EM benjamin-singer@northwestern.edu
FU NIH [K08HL128867, U19AI135964, R01HL149883, P01AG049665, T32GM008152]
FX M.A. Torres Acosta was supported by NIH award T32GM008152. B.D. Singer
   was supported by NIH awards K08HL128867, U19AI135964, R01HL149883, and
   P01AG049665. Funding information for this article has been deposited
   with the Crossref Funder Registry.
CR Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aggarwal NR, 2014, J IMMUNOL, V192, P4453, DOI 10.4049/jimmunol.1400146
   Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   [Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0869-5, DOI 10.1038/S41591-020-0869-5]
   [Anonymous], 2020, LANCET, DOI [10.1016/S0140-6736(20)30211-7, DOI 10.1016/S0140-6736(20)30211-7]
   Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550
   Carlin LE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00781
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Crayne CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00119
   D'Alessio FR, 2016, AM J PHYSIOL-LUNG C, V310, pL733, DOI 10.1152/ajplung.00419.2015
   D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498
   Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413
   De Felice FG, 2020, TRENDS NEUROSCI, V43, P355, DOI 10.1016/j.tins.2020.04.004
   Dial CF, 2017, AM J RESP CELL MOL, V57, P162, DOI 10.1165/rcmb.2017-0019OC
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Jain Juhi, 2020, VirusDisease, V31, P75, DOI 10.1007/s13337-020-00591-1
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006
   Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312
   Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900
   Lerkvaleekul B, 2018, OPEN ACCESS RHEUMATO, V10, P117, DOI 10.2147/OARRR.S151013
   Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074
   Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McGrath-Morrow SA, 2018, J BIOL CHEM, V293, P11772, DOI 10.1074/jbc.RA118.003589
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061
   Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33
   Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480
   Morales-Nebreda L, 2019, TRANSL RES, V204, P1, DOI 10.1016/j.trsl.2018.08.001
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Nicol MQ, 2019, VIROLOGY, V526, P155, DOI 10.1016/j.virol.2018.10.017
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Prabhu N, 2013, J VIROL, V87, P12510, DOI 10.1128/JVI.01776-13
   Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Singer BD, 2019, J CLIN INVEST, V129, P2597, DOI 10.1172/JCI124613
   Singer BD, 2015, AM J RESP CELL MOL, V52, P641, DOI 10.1165/rcmb.2014-0327OC
   Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032
   Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   Topham DJ, 1997, J IMMUNOL, V159, P5197
   Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Voiriot G, 2020, INTERN EMERG MED, V15, P1333, DOI 10.1007/s11739-020-02356-6
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Walter JM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123287
   Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030209, 10.1371/journal.pone.0031048]
   Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z
   WORLD HEALTH ORGANIZATION, COR DIS COVID 19 PAN
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4
   Yang Xiaobo, 2020, Lancet Respir Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
   Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109
NR 91
TC 121
Z9 123
U1 1
U2 20
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD SEP 1
PY 2020
VL 56
IS 3
AR 2002049
DI 10.1183/13993003.02049-2020
PG 12
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA OR0NN
UT WOS:000589173000016
PM 32747391
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Short, KR
   Kroeze, EJBV
   Fouchier, RAM
   Kuiken, T
AF Short, Kirsty R.
   Kroeze, Edwin J. B. Veldhuis
   Fouchier, Ron A. M.
   Kuiken, Thijs
TI Pathogenesis of influenza-induced acute respiratory distress syndrome
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID ALVEOLAR EPITHELIAL-CELLS; VIRUS-INDUCED PNEUMONIA;
   TUMOR-NECROSIS-FACTOR; DOUBLE-STRANDED-RNA; A H5N1 VIRUSES; AVIAN
   INFLUENZA; PANDEMIC INFLUENZA; HUMAN MACROPHAGES; CYTOKINE RESPONSES;
   ENDOTHELIAL-CELLS
AB Acute respiratory distress syndrome (ARDS) is a fatal complication of influenza infection. In this Review we provide an integrated model for its pathogenesis. ARDS involves damage to the epithelial endothelial barrier, fluid leakage into the alveolar lumen, and respiratory insufficiency. The most important part of the epithelial endothelial barrier is the alveolar epithelium, strengthened by tight junctions. Influenza virus targets these epithelial cells, reducing sodium pump activity, damaging tight junctions, and killing infected cells. Infected epithelial cells produce cytokines that attract leucocytes-neutrophils and macrophages and activate adjacent endothelial cells. Activated endothelial cells and infiltrated leucocytes stimulate further infiltration, and leucocytes induce production of reactive oxygen species and nitric oxide that damage the barrier. Activated macrophages also cause direct apoptosis of epithelial cells. This model for influenza-induced ARDS differs from the dassic model, which is centred on endothelial damage, and provides a rationale for therapeutic intervention to moderate host response in influenza-induced ARDS.
C1 [Short, Kirsty R.; Kroeze, Edwin J. B. Veldhuis; Fouchier, Ron A. M.; Kuiken, Thijs] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Zuid Holland, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC
RP Kuiken, T (corresponding author), Erasmus MC, Dept Virosci, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Zuid Holland, Netherlands.
EM t.kuiken@erasmusmc.nl
RI Fouchier, Ron A/A-1911-2014
OI Fouchier, Ron A/0000-0001-8095-2869; Short, Kirsty/0000-0003-4963-6184;
   Kuiken, Thijs/0000-0001-5501-9049
FU NHMRC CJ Martin postdoctoral fellowship [1054081]; NIH/NIAID
   [HHSN266200700010C]; European Union FP7 ANTIGONE [278976]
FX We thank Lonneke Leijten for doing Pankeratin and von Willebrand factor
   staining. We thank Judith van den Brand for the provision of histology
   sections and Debby van Riel for the provision of histology sections and
   critical reading of the Review. KRS is supported by an NHMRC CJ Martin
   postdoctoral fellowship (1054081). RAMF is supported by NIH/NIAID
   contract HHSN266200700010C. TK is supported by European Union FP7
   ANTIGONE contract 278976.
CR Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584
   Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448
   Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7
   Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Arndt U, 2002, J VIROL, V76, P9298, DOI 10.1128/JVI.76.18.9298-9306.2002
   Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658
   Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006
   Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540
   Bemasconi D, 2005, J BIOL CHEM, V280, P24127
   Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010
   Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313
   Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016
   Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0
   Budinger GRS, 2006, CLIN CHEST MED, V27, P655, DOI 10.1016/j.ccm.2006.06.007
   Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08
   Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135
   Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102
   Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004
   Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7
   Chien YW, 2009, NEW ENGL J MED, V361, P2582, DOI 10.1056/NEJMc0908216
   Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797
   CHOI AMK, 1992, FEBS LETT, V309, P327, DOI 10.1016/0014-5793(92)80799-M
   Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061
   Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09
   Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7
   Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004
   Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030
   Folkesson HG, 2006, AM J RESP CELL MOL, V35, P10, DOI 10.1165/rcmb.2006-0080SF
   Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y
   Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11
   GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315
   Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3
   Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001
   Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200
   Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI 10.2217/FMB.09.108
   Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043
   Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817
   Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201
   Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188
   HOLT PG, 1986, CLIN EXP IMMUNOL, V63, P261
   Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a
   Huber D, 1999, INVAS METAST, V18, P70
   Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088
   Husain AN, 2010, ROBBINS COTRAN PATHO, P715
   Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ishiguro N, 2004, ARCH VIROL, V149, P17, DOI 10.1007/s00705-003-0208-4
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541
   Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013
   Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809
   Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651
   Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025
   Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997
   Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   LEFKOWITZ DL, 1995, MED HYPOTHESES, V44, P58, DOI 10.1016/0306-9877(95)90303-8
   Lehmann C, 1996, RES VIROLOGY, V147, P123, DOI 10.1016/0923-2516(96)80226-3
   MARTIN TR, 1989, J CLIN INVEST, V84, P1609, DOI 10.1172/JCI114338
   Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542
   Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC
   Michaelis M, 2010, MED MICROBIOL IMMUN, V199, P291, DOI 10.1007/s00430-010-0155-0
   Mok KP, 2009, J INFECT DIS, V200, P1104, DOI 10.1086/605606
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989
   MULLIN JM, 1990, CANCER RES, V50, P2172
   Nakajima N, 2013, MODERN PATHOL, V26, P357, DOI 10.1038/modpathol.2012.193
   Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09
   ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070
   Okada T, 2011, J STRENGTH COND RES, V25, P252, DOI 10.1519/JSC.0b013e3181b22b3e
   Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09
   Padalko E, 2004, P NATL ACAD SCI USA, V101, P11731, DOI 10.1073/pnas.0400518101
   Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540
   Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004
   Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5
   Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   PINKERTON KE, 1992, COMP BIOL NORMAL LUN, P121
   Pirhonen J, 1999, J IMMUNOL, V162, P7322
   Ramsey C, 2011, CURR OPIN CRIT CARE, V17, P64, DOI 10.1097/MCC.0b013e3283427259
   Reperant LA, 2012, J VIROL, V86, P1158, DOI 10.1128/JVI.06375-11
   Roux J, 2005, J BIOL CHEM, V280, P18579, DOI 10.1074/jbc.M410561200
   Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000
   Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104
   SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996
   Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757
   Sevransky JE, 2009, CRIT CARE, V13, DOI 10.1186/cc8048
   Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977
   Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002
   Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1
   Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x
   Sumikoshi M, 2008, J MED VIROL, V80, P1072, DOI 10.1002/jmv.21185
   Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06
   Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996
   Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613
   Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10
   Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497
   Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581
   Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572
   Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313
   Valberg PA, 1992, COMP BIOL NORMAL LUN, P681
   van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548
   van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248
   van Riel D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002099
   Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8
   Vissers MCM, 1999, BIOCHEM J, V344, P443, DOI 10.1042/0264-6021:3440443
   Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271
   von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0
   WALKER DC, 1995, MICROVASC RES, V50, P397, DOI 10.1006/mvre.1995.1067
   Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860
   Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024
   WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218
   WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388
   Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC
   Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785
   Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207
   YAMAMOTO K, 1991, J INFECT DIS, V164, P8, DOI 10.1093/infdis/164.1.8
   Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10
   Zeng H, 2013, J VIROL, V87, P2597, DOI 10.1128/JVI.02885-12
   Zeng H, 2012, J VIROL, V86, P667, DOI 10.1128/JVI.06348-11
   Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105
NR 139
TC 334
Z9 362
U1 10
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2014
VL 14
IS 1
BP 57
EP 69
DI 10.1016/S1473-3099(13)70286-X
PG 13
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 281DC
UT WOS:000329079100022
PM 24239327
DA 2023-08-21
ER

PT J
AU Whyte, CS
   Morrow, GB
   Mitchell, JL
   Chowdary, P
   Mutch, NJ
AF Whyte, Claire S.
   Morrow, Gael B.
   Mitchell, Joanne L.
   Chowdary, Pratima
   Mutch, Nicola J.
TI Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS)
   and versatility of thrombolytic drugs to treat COVID-19
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Review
DE fibrin; fibrinolysis; plasminogen activator inhibitor 1; respiratory distress syndrome, adult; COVID-19/SARS-CoV-2/Coronavirus; tissue plasminogen activator 
ID ACUTE LUNG INJURY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; TISSUE FACTOR;
   ELEVATED LEVELS; FACTOR XA; COAGULATION; EXPRESSION; PNEUMONIA;
   INTERLEUKIN-8; MACROPHAGE
AB The global pandemic of coronavirus disease 2019 (COVID-19) is associated with the development of acute respiratory distress syndrome (ARDS), which requires ventilation in critically ill patients. The pathophysiology of ARDS results from acute inflammation within the alveolar space and prevention of normal gas exchange. The increase in proinflammatory cytokines within the lung leads to recruitment of leukocytes, further propagating the local inflammatory response. A consistent finding in ARDS is the deposition of fibrin in the air spaces and lung parenchyma. COVID-19 patients show elevated D-dimers and fibrinogen. Fibrin deposits are found in the lungs of patients due to the dysregulation of the coagulation and fibrinolytic systems. Tissue factor (TF) is exposed on damaged alveolar endothelial cells and on the surface of leukocytes promoting fibrin deposition, while significantly elevated levels of plasminogen activator inhibitor 1 (PAI-1) from lung epithelium and endothelial cells create a hypofibrinolytic state. Prophylaxis treatment of COVID-19 patients with low molecular weight heparin (LMWH) is important to limit coagulopathy. However, to degrade pre-existing fibrin in the lung it is essential to promote local fibrinolysis. In this review, we discuss the repurposing of fibrinolytic drugs, namely tissue-type plasminogen activator (tPA), to treat COVID-19 associated ARDS. tPA is an approved intravenous thrombolytic treatment, and the nebulizer form has been shown to be effective in plastic bronchitis and is currently in Phase II clinical trial. Nebulizer plasminogen activators may provide a targeted approach in COVID-19 patients to degrade fibrin and improving oxygenation in critically ill patients.
C1 [Whyte, Claire S.; Morrow, Gael B.; Mutch, Nicola J.] Aberdeen Cardiovasc & Diabet Ctr, Sch Med Med Sci & Nutr, Aberdeen, Scotland, United Kingdom.
   [Morrow, Gael B.] Univ Oxford, Radcliffe Dept Med, Oxford, England, United Kingdom.
   [Mitchell, Joanne L.] Univ Reading, Inst Cardiovasc & Metab Sci, Sch Biol Sci, Reading, Berks, England, United Kingdom.
   [Chowdary, Pratima] Royal Free Hosp, Katharine Dormandy Haemophilia & Thrombosis Ctr, London, England, United Kingdom.
C3 University of Oxford; University of Reading; University of London;
   University College London; Royal Free London NHS Foundation Trust; UCL
   Medical School
RP Mutch, NJ (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Cardiovasc & Diabet Ctr, Foresterhill, Aberdeen AB25 2ZD, Scotland.
EM n.j.mutch@abdn.ac.uk
RI Chowdary, Pratima/I-2623-2012
OI Chowdary, Pratima/0000-0002-6690-8586; Morrow, Gael
   B/0000-0001-9299-6754; Whyte, Claire/0000-0001-8127-6102; Mutch,
   Nicola/0000-0002-7452-0813
FU British Heart Foundation [FS/11/2/28579, PG/15/82/31721]
FX British Heart Foundation, Grant/Award Number: FS/11/2/28579,
   PG/15/82/31721
CR Armstrong L, 1997, THORAX, V52, P442, DOI 10.1136/thx.52.5.442
   Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577
   Bendib I, 2019, ANESTHESIOLOGY, V130, P581, DOI 10.1097/ALN.0000000000002619
   BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304
   Blanc-Brude OP, 2005, EXP CELL RES, V304, P16, DOI 10.1016/j.yexcr.2004.10.021
   Blanc-Brude OP, 2001, AM J PHYSIOL-CELL PH, V281, pC681, DOI 10.1152/ajpcell.2001.281.2.C681
   Bodier-Montagutelli E, 2018, EXPERT OPIN DRUG DEL, V15, P729, DOI 10.1080/17425247.2018.1503251
   BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2
   BRISSENDEN JE, 1983, CLIN CHIM ACTA, V128, P241, DOI 10.1016/0009-8981(83)90324-8
   BROWN LF, 1993, AM J PATHOL, V142, P273
   Camprubi-Rimblas M, 2020, J THROMB HAEMOST, V18, P571, DOI 10.1111/jth.14685
   Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200
   CHOLLETMARTIN S, 1993, INFECT IMMUN, V61, P4553, DOI 10.1128/IAI.61.11.4553-4559.1993
   Colaneri M, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-18
   Deng JK, 2010, CHEST, V138, P1486, DOI 10.1378/chest.10-0548
   Determann RM, 2006, INTENS CARE MED, V32, P946, DOI 10.1007/s00134-006-0167-9
   DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E
   DOWTON SB, 1988, SEMIN HEMATOL, V25, P84
   Duffy AJ, 2000, J SURG RES, V90, P51, DOI 10.1006/jsre.2000.5835
   El Solh AA, 2006, INTENS CARE MED, V32, P110, DOI 10.1007/s00134-005-2847-2
   Enkhbaatar P, 2007, CRIT CARE MED, V35, P2805, DOI 10.1097/01.CCM.0000291647.18329.83
   Fujimoto H, 2003, AM J RESP CRIT CARE, V167, P1687, DOI 10.1164/rccm.200208-905OC
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13
   Gram J, 1999, FIBRINOLYSIS PROTEOL, V13, P209, DOI 10.1016/S0268-9499(99)90073-5
   GUNTHER A, 1995, AM J RESP CELL MOL, V13, P712
   Hardaway RM, 2001, AM SURGEON, V67, P377
   HARDAWAY RM, 1990, CRIT CARE MED, V18, P1413, DOI 10.1097/00003246-199012000-00021
   Hardaway RM, 2006, WORLD J SURG, V30, P1829, DOI 10.1007/s00268-006-0030-8
   Hasegawa M, 2010, EMERG INFECT DIS, V16, P344, DOI 10.3201/eid1602.091607
   He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067
   Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang XF, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1264913
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   HUNT B, 2020, BR SOC HAEMATOL, DOI DOI 10.1111/JTH.14853
   Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB
   IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240
   IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217
   Idell S, 1994, New Horiz, V2, P566
   Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC
   Jose RJ, 2014, THORAX, V69, P190, DOI 10.1136/thoraxjnl-2013-204367
   Juschten J, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.08.23
   Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274
   Laterre PF, 2003, CRIT CARE MED, V31, pS329, DOI 10.1097/01.CCM.0000057912.71499.A5
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lefrancais E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98178
   Li Haitao, 2018, Oncotarget, V9, P1772, DOI 10.18632/oncotarget.22744
   Liu C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01898
   Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   MacLaren R, 2007, PHARMACOTHERAPY, V27, P860, DOI 10.1592/phco.27.6.860
   Mahmoud AAA, 2020, J CARDIOTHOR VASC AN, V34, P436, DOI 10.1053/j.jvca.2019.05.035
   MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Meduri GU, 2009, CHEST, V136, P1631, DOI 10.1378/chest.08-2408
   Mikacenic C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2290-8
   Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001
   Moore HB, 2020, J TRAUMA ACUTE CARE, V88, P713, DOI 10.1097/TA.0000000000002694
   Morrow B, 2019, 2019 IEEE VISUALIZATION CONFERENCE (VIS), P1, DOI 10.1109/VISUAL.2019.8933582
   Mousavi S, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/507151
   Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006
   Oikawa J, 2009, PEDIATR INFECT DIS J, V28, P1035, DOI 10.1097/INF.0b013e3181ac4d0d
   Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105
   Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002
   Rocco PRM, 2009, MINERVA ANESTESIOL, V75, P730
   Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25
   Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04
   Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI [10.1097/01.CCM.0000201882.23917.B8, 10.1097/01.CCM.0000202136.91651.34]
   Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481
   SEEGER W, 1985, J APPL PHYSIOL, V58, P326, DOI 10.1152/jappl.1985.58.2.326
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Simpson-Haidaris PJ, 1998, INFECT IMMUN, V66, P4431
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   Song YL, 2007, ANESTHESIOLOGY, V106, P252, DOI 10.1097/00000542-200702000-00012
   Stringer KA, 1998, FREE RADICAL BIO MED, V25, P184, DOI 10.1016/S0891-5849(98)00047-1
   Tan YJ, 2005, J VIROL, V79, P10083, DOI 10.1128/JVI.79.15.10083-10087.2005
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Ueno A, 1996, IMMUNOLOGY, V88, P76, DOI 10.1046/j.1365-2567.1996.d01-635.x
   Wang Dawei, 2020, JAMA, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, 2020, J THROMB HAEMOST, V18, P1752, DOI 10.1111/jth.14828
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Ware LB, 2007, CRIT CARE MED, V35, P1821, DOI 10.1097/01.CCM.0000275386.95968.5F
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Ware LB, 2006, AM J PHYSIOL-LUNG C, V291, pL307, DOI 10.1152/ajplung.00157.2006
   Whyte CS, 2015, BLOOD, V125, P2568, DOI 10.1182/blood-2014-09-599480
   Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358
   Xu S P, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P354, DOI 10.3760/cma.j.cn112151.20200219.00001
   Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Xue MM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0518-9
   Yang Xiaobo, 2020, Lancet Respir Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yao XH, 2020, CHINESE J PATHOL, V49, P411
   Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533
   Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200
NR 96
TC 175
Z9 188
U1 3
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD JUL
PY 2020
VL 18
IS 7
BP 1548
EP 1555
DI 10.1111/jth.14872
EA JUN 2020
PG 8
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA MG6WK
UT WOS:000537272200001
PM 32329246
OA hybrid, Green Published, Green Accepted
DA 2023-08-21
ER

PT J
AU Abrams, ST
   Zhang, N
   Manson, J
   Liu, TT
   Dart, C
   Baluwa, F
   Wang, SS
   Brohi, K
   Kipar, A
   Yu, WP
   Wang, GZ
   Toh, CH
AF Abrams, Simon T.
   Zhang, Nan
   Manson, Joanna
   Liu, Tingting
   Dart, Caroline
   Baluwa, Florence
   Wang, Susan Siyu
   Brohi, Karim
   Kipar, Anja
   Yu, Weiping
   Wang, Guozheng
   Toh, Cheng-Hock
TI Circulating Histones Are Mediators of Trauma-associated Lung Injury
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Article
DE lung; trauma; histones 
ID MULTIPLE ORGAN FAILURE; EXTRACELLULAR HISTONES; THROMBIN GENERATION;
   PROTEIN; BINDING; DEATH; IDENTIFICATION; PERMEABILITY; NEUTROPHILS;
   RECEPTOR
AB Rationale: Acute lung injury is a common complication after severe trauma, which predisposes patients to multiple organ failure. This syndrome largely accounts for the late mortality that arises and despite many theories, the pathological mechanism is not fully understood. Discovery of histone-induced toxicity in mice presents a new dimension for elucidating the underlying pathophysiology.
   Objectives: To investigate the pathological roles of circulating histones in trauma-induced lung injury.
   Methods: Circulating histone levels in patients with severe trauma were determined and correlated with respiratory failure and Sequential Organ Failure Assessment (SOFA) scores. Their cause effect relationship was studied using cells and mouse models.
   Measurements and Main Results: In a cohort of 52 patients with severe nonthoracic blunt trauma, circulating histones surged immediately after trauma to levels that were toxic to cultured endothelial cells. The high levels were significantly associated with the incidence of acute lung injury and SOFA scores, as well as markers of endothelial damage and coagulation activation. In in vitro systems, histones damaged endothelial cells, stimulated cytokine release, and induced neutrophil extracellular trap formation and myeloperoxidase release. Cellular toxicity resulted from their direct membrane interaction and resultant calcium influx. In mouse models, cytokines and markers for endothelial damage and coagulation activation significantly increased immediately after trauma or histone infusion. Pathological examinations showed that lungs were the predominantly affected organ with edema, hemorrhage, microvascular thrombosis, and neutrophil congestion. An anti-histone antibody could reduce these changes and protect mice from histone-induced lethality.
   Conclusions: This study elucidates a new mechanism for acute lung injury after severe trauma and proposes that circulating histones are viable therapeutic targets for improving survival outcomes in patients.
C1 [Abrams, Simon T.; Toh, Cheng-Hock] Royal Liverpool Univ Hosp, Natl Inst Hlth Res, Biomed Res Ctr, Liverpool L7 8XP, Merseyside, England, United Kingdom.
   [Abrams, Simon T.; Liu, Tingting; Baluwa, Florence; Wang, Guozheng; Toh, Cheng-Hock] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3GA, Merseyside, England, United Kingdom.
   [Zhang, Nan; Yu, Weiping] Southeast Univ, Sch Med, Nanjing, Jiangsu, China.
   [Manson, Joanna; Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England, United Kingdom.
   [Dart, Caroline] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England, United Kingdom.
   [Wang, Susan Siyu] Univ Cambridge, Sch Clin Med, Cambridge, England, United Kingdom.
   [Kipar, Anja] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England, United Kingdom.
C3 Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal
   Liverpool University Hospital; University of Liverpool; University of
   Liverpool; Southeast University - China; University of London; Queen
   Mary University London; University of Liverpool; University of
   Cambridge; University of Liverpool
RP Toh, CH (corresponding author), Royal Liverpool Univ Hosp, Natl Inst Hlth Res, Biomed Res Ctr, Liverpool L7 8XP, Merseyside, England.
EM wangg@liv.ac.uk; toh@liv.ac.uk
RI Kipar, Anja/L-7214-2014; liu, ting/GZM-3326-2022
OI Kipar, Anja/0000-0001-7289-3459; Dart, Caroline/0000-0002-3509-8349;
   Wang, Susan Siyu/0000-0002-6546-8240; Abrams, Simon/0000-0003-3949-2455
FU Royal College of Surgeons, England; National Institute of Health
   Research (NIHR Biomedical Research Centre in Microbial Disease) [3515];
   National Institute of Health Research (NIHR Innovation for Invention
   Grant) [II-LS-1010-14061]; National Institutes of Health Research (NIHR)
   [BRF-2011-026, II-FS-0509-12093, II-LS-1010-10045] Funding Source:
   National Institutes of Health Research (NIHR); National Institute for
   Health Research [II-FS-0509-12093, BRF-2011-026, II-LS-1010-10045]
   Funding Source: researchfish
FX The authors are indebted to participating patients and their attending
   clinical staff. J.M. has a research fellowship from the Royal College of
   Surgeons, England. The authors also acknowledge the National Institute
   of Health Research (NIHR Biomedical Research Centre in Microbial Disease
   Grant Project [3515] and NIHR Innovation for Invention Grant
   [II-LS-1010-14061]) for infrastructural and project support.
CR Abakushin DN, 1999, BIOCHEMISTRY-MOSCOW+, V64, P693
   Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   Becker PM, 2003, AM J RESP CELL MOL, V28, P478, DOI 10.1165/rcmb.2002-0024OC
   Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x
   Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020
   Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030
   Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024
   Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676
   Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107
   Ganapathy V, 2005, LIFE SCI, V76, P2631, DOI 10.1016/j.lfs.2005.01.002
   Gauthier VJ, 1996, J IMMUNOL, V156, P1151
   Gierer P, 2008, J SURG RES, V147, P68, DOI 10.1016/j.jss.2007.07.025
   GIL J, 1980, ANNU REV PHYSIOL, V42, P177, DOI 10.1146/annurev.ph.42.030180.001141
   Gil J, 2011, TEXTBOOK OF PULMONARY VASCULAR DISEASE, P13, DOI 10.1007/978-0-387-87429-6_2
   Gomberg BFC, 1999, INJURY, V30, P431, DOI 10.1016/S0020-1383(99)00138-2
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   HAALAND AK, 1991, THROMB RES, V61, P253, DOI 10.1016/0049-3848(91)90101-2
   Holdenrieder S, 2001, ANN NY ACAD SCI, V945, P93
   Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875, 10.1080/10408360802485875 ]
   Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501
   Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679
   Kleine TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1925, DOI 10.1152/ajpcell.1997.273.6.C1925
   Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200
   Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239
   Li YQ, 2011, SURGERY, V150, P442, DOI 10.1016/j.surg.2011.07.003
   Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444
   Malangoni MA, 2005, SURGERY, V138, P757
   MARTIN AM, 1968, J TRAUM, V8, P687, DOI 10.1097/00005373-196809000-00007
   MONESTIER M, 1993, MOL IMMUNOL, V30, P1069, DOI 10.1016/0161-5890(93)90153-3
   Moore EE, 2005, SHOCK, V24, P71, DOI 10.1097/01.shk.0000191336.01036.fe
   Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7
   ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1
   Partrick D A, 1996, New Horiz, V4, P194
   Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173
   Pemberton AD, 2010, PROTEOMICS, V10, P1484, DOI 10.1002/pmic.200900818
   PEREIRA LF, 1994, CLIN EXP IMMUNOL, V97, P175
   Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547
   Perl M, 2012, SHOCK, V38, P98, DOI 10.1097/SHK.0b013e318254be6a
   Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366
   Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061
   Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202
   Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092
   Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065
   Tsukamoto T, 2010, INJURY, V41, P21, DOI 10.1016/j.injury.2009.07.010
   Wang G, 2012, 4 ANN INT C ANT ICA
   Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930
   Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053
   Zallen G, 1999, J TRAUMA, V46, P42, DOI 10.1097/00005373-199901000-00007
NR 51
TC 378
Z9 404
U1 1
U2 59
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PD JAN 15
PY 2013
VL 187
IS 2
BP 160
EP 169
DI 10.1164/rccm.201206-1037OC
PG 10
WC Critical Care Medicine; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Respiratory System
GA 075YY
UT WOS:000313924600012
PM 23220920
OA Green Published
DA 2023-08-21
ER

PT J
AU van de Veerdonk, FL
   Netea, MG
   van Deuren, M
   van der Meer, JWM
   de Mast, Q
   Bruggemann, RJ
   van der Hoeven, H
AF van de Veerdonk, Frank L.
   Netea, Mihai G.
   van Deuren, Marcel
   van der Meer, Jos W. M.
   de Mast, Quirijn
   Brueggemann, Roger J.
   van der Hoeven, Hans
TI Kallikrein-kinin blockade in patients with COVID-19 to prevent acute
   respiratory distress syndrome
SO ELIFE
LA English
DT Article
ID RECEPTORS
AB COVID-19 patients can present with pulmonary edema early in disease. We propose that this is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. SARS-CoV-2 enters the cell via ACE2 that next to its role in RAAS is needed to inactivate des-Arg9 bradykinin, the potent ligand of the B1R. Without ACE2 acting as a guardian to inactivate the ligands of B1R, the lung environment is prone for local vascular leakage leading to angioedema. Here, we hypothesize that a kinin-dependent local lung angioedema via B1R and eventually B2R is an important feature of COVID-19. We propose that blocking the B2R and inhibiting plasma kallikrein activity might have an ameliorating effect on early disease caused by COVID-19 and might prevent acute respiratory distress syndrome (ARDS). In addition, this pathway might indirectly be responsive to anti-inflammatory agents.
C1 [van de Veerdonk, Frank L.; Netea, Mihai G.; van Deuren, Marcel; van der Meer, Jos W. M.; de Mast, Quirijn] Radboudumc Ctr Infect Dis RCI, Dept Internal Med, Nijmegen, Netherlands.
   [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, Bonn, Germany.
   [Brueggemann, Roger J.] Radboudumc Ctr Infect Dis RCI, Dept Pharm, Nijmegen, Netherlands.
   [van der Hoeven, Hans] Radboudumc Ctr Infect Dis RCI, Intens Care, Nijmegen, Netherlands.
C3 University of Bonn
RP van de Veerdonk, FL (corresponding author), Radboudumc Ctr Infect Dis RCI, Dept Internal Med, Nijmegen, Netherlands.
EM frank.vandeveerdonk@radboudumc.nl
RI van de Veerdonk, Frank L/C-7256-2008
OI van de Veerdonk, Frank L/0000-0002-1121-4894; de Mast,
   Quirijn/0000-0001-6056-157X
CR [Anonymous], 2020, J CLIN MED, DOI DOI 10.3390/jcm9020538
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   BHOOLA KD, 1992, PHARMACOL REV, V44, P1
   Ceravolo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111117
   European Medicines Agency, 2014, ASS REP FIR INN IC
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fu Y, 2020, VIROL SIN, V85, P4006, DOI DOI 10.1007/212250-020-00207-4
   Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuduk SD, 2007, J MED CHEM, V50, P272, DOI 10.1021/jm061094b
   Levi M, 2019, RES PRACT THROMB HAE, V3, P38, DOI 10.1002/rth2.12175
   Marceau F, 2018, PEPTIDES, V105, P37, DOI 10.1016/j.peptides.2018.05.007
   Nasseri S, 2015, CRIT CARE MED, V43, pE499, DOI 10.1097/CCM.0000000000001268
   Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839
   Qadri F, 2018, EXPERT OPIN THER TAR, V22, P31, DOI 10.1080/14728222.2018.1409724
   Quitterer U, 2014, BIOCHEM PHARMACOL, V88, P284, DOI 10.1016/j.bcp.2014.01.019
   Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Zekayi Kutlubay, 2017, COMPREHENSIVE REV UR, P151, DOI DOI 10.5772/67704
NR 23
TC 189
Z9 193
U1 1
U2 9
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD APR 27
PY 2020
VL 9
AR e57555
DI 10.7554/eLife.57555
PG 9
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA LL9QT
UT WOS:000531890700001
PM 32338605
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Hojyo, S
   Uchida, M
   Tanaka, K
   Hasebe, R
   Tanaka, Y
   Murakami, M
   Hirano, T
AF Hojyo, Shintaro
   Uchida, Mona
   Tanaka, Kumiko
   Hasebe, Rie
   Tanaka, Yuki
   Murakami, Masaaki
   Hirano, Toshio
TI How COVID-19 induces cytokine storm with high mortality
SO INFLAMMATION AND REGENERATION
LA English
DT Review
ID ANGIOTENSIN-CONVERTING ENZYME-2; ACUTE RESPIRATORY SYNDROME; FUNCTIONAL
   RECEPTOR; SARS CORONAVIRUS; VIRAL LOAD; INFLAMMATION; TOCILIZUMAB;
   ACTIVATION; ACE2; INHIBITION
AB The newly emerging coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, but has rapidly spread all over the world. Some COVID-19 patients encounter a severe symptom of acute respiratory distress syndrome (ARDS) with high mortality. This high severity is dependent on a cytokine storm, most likely induced by the interleukin-6 (IL-6) amplifier, which is hyperactivation machinery that regulates the nuclear factor kappa B (NF-kappa B) pathway and stimulated by the simultaneous activation of IL-6-signal transducer and activator of transcription 3 (STAT3) and NF-kappa B signaling in non-immune cells including alveolar epithelial cells and endothelial cells. We hypothesize that IL-6-STAT3 signaling is a promising therapeutic target for the cytokine storm in COVID-19, because IL-6 is a major STAT3 stimulator, particularly during inflammation. We herein review the pathogenic mechanism and potential therapeutic targets of ARDS in COVID-19 patients.
C1 [Hojyo, Shintaro; Uchida, Mona; Tanaka, Kumiko; Hasebe, Rie; Tanaka, Yuki; Murakami, Masaaki; Hirano, Toshio] Hokkaido Univ, Inst Genet Med, Grad Sch Med, Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.
   [Hirano, Toshio] Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan.
C3 Hokkaido University; National Institutes for Quantum Science &
   Technology
RP Murakami, M; Hirano, T (corresponding author), Hokkaido Univ, Inst Genet Med, Grad Sch Med, Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.
EM murakami@igm.hokudai.ac.jp; hirano-toshio@qst.go.jp
RI Uchida, Mona/AAK-1828-2021; Hirano, Toshio/C-8194-2009
OI , Masaaki/0000-0001-7159-7279; HASEBE, Rie/0000-0003-2009-0595
CR [Anonymous], 2020, JAMA, DOI DOI 10.1038/s41422-020-0282-0
   [Anonymous], 2020, IMMUNITY, DOI DOI 10.1016/J.IMMUNI.2020.04.003
   [Anonymous], 2020, J KOREAN MED SCI
   Arima Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25517
   Arima Y, 2015, ELIFE, V4, DOI 10.7554/eLife.08733
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Eguchi S, 2018, HYPERTENSION, V71, P804, DOI 10.1161/HYPERTENSIONAHA.118.10266
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fujita M, 2019, J INVEST DERMATOL, V139, P333, DOI 10.1016/j.jid.2018.07.044
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Harada M, 2015, J IMMUNOL, V194, P1039, DOI 10.4049/jimmunol.1400562
   Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kennedy GA, 2014, LANCET ONCOL, V15, P1451, DOI 10.1016/S1470-2045(14)71017-4
   Kim JY, 2020, J KOREAN MED SCI, V35
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lamb YN, 2018, DRUGS, V78, P929, DOI 10.1007/s40265-018-0929-z
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lee J, 2013, INT IMMUNOL, V25, P319, DOI 10.1093/intimm/dxs158
   Levi M, 2008, SEMIN THROMB HEMOST, V34, P26, DOI 10.1055/s-2008-1066020
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   Magro G, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198070
   Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
   Matsuzawa Y, HYPERTENS RES
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Mogul A, 2019, ANN PHARMACOTHER, V53, P947, DOI 10.1177/1060028019839650
   Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027
   Murakami M, 2013, CELL REP, V3, P946, DOI 10.1016/j.celrep.2013.01.028
   Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148
   Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018
   Ota M, 2020, ARTHRITIS RHEUMATOL, V72, P931, DOI 10.1002/art.41182
   Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Qin C, 2020, CLIN INFECT DIS CHIN
   Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005
   Sheng F, 2016, PHARMAZIE, V71, P636, DOI 10.1691/ph.2016.6713
   Tang N., 2020, JAMA-J AM MED ASSOC, V18, P844, DOI [DOI 10.1001/JAMA.2020.7869, 10.1111/jth.14768]
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36
   Verdecchia Paolo, 2020, Eur J Intern Med, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wrapp D, 2020, BIORXIV
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yi XH, 2010, AM J RESP CRIT CARE, V182, P436, DOI 10.1164/ajrccm.182.3.436
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
NR 76
TC 356
Z9 362
U1 2
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1880-8190
J9 INFLAMM REGEN
JI Inflamm. Regen.
PD OCT 1
PY 2020
VL 40
IS 1
AR 37
DI 10.1186/s41232-020-00146-3
PG 7
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA NZ2DO
UT WOS:000576905800001
PM 33014208
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Batah, SS
   Fabro, AT
AF Batah, Sabrina Setembre
   Fabro, Alexandre Todorovic
TI Pulmonary pathology of ARDS in COVID-19: A pathological review for
   clinicians
SO RESPIRATORY MEDICINE
LA English
DT Review
DE COVID-19/SARS-CoV-2/Coronavirus; Pulmonary pathology; Molecular pathology; DAD 
ID ACUTE RESPIRATORY-DISTRESS; ANGIOTENSIN-CONVERTING ENZYME-2; DIFFUSE
   ALVEOLAR DAMAGE; LUNG PATHOLOGY; SYNDROME SARS; CHLOROQUINE; INFECTIONS;
   CORONAVIRUSES; EPIDEMIOLOGY; EDEMA
AB COVID-19 has quickly reached pandemic levels since it was first reported in December 2019. The virus responsible for the disease, named SARS-CoV-2, is enveloped positive-stranded RNA viruses. During its replication in the cytoplasm of host cells, the viral genome is transcribed into proteins, such as the structural protein spike domain S1, which is responsible for binding to the cell receptor of the host cells. Infected patients have initially flu-like symptoms, rapidly evolving to severe acute lung injury, known as acute respiratory distress syndrome (ARDS). ARDS is characterized by an acute and diffuse inflammatory damage into the alveolar-capillary barrier associated with a vascular permeability increase and reduced compliance, compromising gas exchange and causing hypoxemia. Histopathologically, this condition is known as diffuse alveolar damage which consists of permanent damage to the alveoli epithelial cells and capillary endothelial cells, with consequent hyaline membrane formation and eventually intracapillary thrombosis. All of these mechanisms associated with COVID-19 involve the phenotypic expression from different proteins transcription modulated by viral infection in specific pulmonary microenvimnments. Therefore, this knowledge is fundamentally important for a better pathophysiological understanding and identification of the main molecular pathways associated with the disease evolution. Evidently, clinical findings, signs and symptoms of a patient are the phenotypic expression of these pathophysiological and molecular mechanisms of SARS-CoV-2 infection. Therefore, no findings alone, whether molecular, clinical, radiological or pathological axis are sufficient for an accurate diagnosis. However, their intersection and/or correlation are extremely critical for clinicians establish the diagnosis and new treatment perspectives.
C1 [Batah, Sabrina Setembre; Fabro, Alexandre Todorovic] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo
RP Fabro, AT (corresponding author), Univ Sao Paulo, Dept Pathol & Legal Med, FMRP, Ave Bandeirantes 3900, BR-14049 Ribeirao Preto, SP, Brazil.
EM fabro@fmrp.usp.br
RI Fabro, Alexandre Todorovic/F-6792-2013
OI Fabro, Alexandre Todorovic/0000-0002-7687-3161
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Hazmi A, 2016, SAUDI J BIOL SCI, V23, P507, DOI 10.1016/j.sjbs.2016.02.019
   [Anonymous], 2020, RAP RESP US ANG REC
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Babiker A, 2020, AM J CLIN PATHOL, V153, P706, DOI [10.1093/ajcp/aqaa052, 10.1093/AJCP/AQAA052]
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Brigham KL, 1998, AM J RESP CRIT CARE, V157, pS109, DOI 10.1164/ajrccm.157.4.nhlbi-8
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
   Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Franks TJ, 2003, HUM PATHOL, V34, P743, DOI 10.1016/S0046-8177(03)00367-8
   Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Grillo F, 2020, LANCET INFECT DIS, V21, pE72, DOI 10.1016/S1473-3099(20)30582-X
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   Holmes EC., 2020, NOVEL 2019 CORONAVIR
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210
   Konopka KE, 2020, CHEST, V158, pE99, DOI 10.1016/j.chest.2020.04.032
   Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lacy JM, 2020, AM J FOREN MED PATH, V41, P143, DOI 10.1097/PAF.0000000000000567
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Meyer NJ, 2017, LANCET RESP MED, V5, P512, DOI 10.1016/S2213-2600(17)30187-X
   Nagata N, 2008, AM J PATHOL, V172, P1625, DOI 10.2353/ajpath.2008.071060
   Nicholls J, 2003, RESPIROLOGY, V8, pS6, DOI 10.1046/j.1440-1843.2003.00517.x
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Pei Fei, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P656
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Schwensen HF, 2021, J CLIN PATHOL, V74, P400, DOI 10.1136/jclinpath-2020-206879
   Pham T, 2017, AM J RESP CRIT CARE, V195, P860, DOI 10.1164/rccm.201609-1773CP
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Universidade John Hopkins E. Baltimore, 2020, COR COVID 19 GLOB CA
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
   Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 58
TC 140
Z9 144
U1 2
U2 24
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0954-6111
EI 1532-3064
J9 RESP MED
JI Respir. Med.
PD JAN
PY 2021
VL 176
AR 106239
DI 10.1016/j.rmed.2020.106239
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Respiratory System
GA QH8NN
UT WOS:000618529000011
PM 33246294
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Schaefer, IM
   Padera, RF
   Solomon, IH
   Kanjilal, S
   Hammer, MM
   Hornick, JL
   Sholl, LM
AF Schaefer, Inga-Marie
   Padera, Robert F.
   Solomon, Isaac H.
   Kanjilal, Sanjat
   Hammer, Mark M.
   Hornick, Jason L.
   Sholl, Lynette M.
TI In situ detection of SARS-CoV-2 in lungs and airways of patients with
   COVID-19
SO MODERN PATHOLOGY
LA English
DT Article
ID FOXJ1 EXPRESSION; CILIOGENESIS; INFECTION
AB Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has led to a global public health crisis. In elderly individuals and those with comorbidities, COVID-19 is associated with high mortality, frequently caused by acute respiratory distress syndrome. We examine in situ expression of SARS-CoV-2 in airways and lung obtained at autopsy of individuals with confirmed COVID-19 infection. Seven autopsy cases (male,N = 5; female,N = 2) with reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection and a median age of 66 years (range, 50-77 years) were evaluated using a rabbit polyclonal antibody against SARS Nucleocapsid protein in correlation with clinical parameters. The median time from symptom onset to death was 9 days (range, 6-31 days), from hospitalization 7 days (range, 1-21 days), from positive RT-PCR 7 days (range, 0-18 days), and from intensive care unit admission defining onset of respiratory failure 3 days (range, 1-18 days). Chest imaging identified diffuse airspace disease in all patients corresponding to acute and (N = 5) or organizing (N = 2) diffuse alveolar damage (DAD) on histologic examination. Among five patients with acute-phase DAD (<= 7 days from onset of respiratory failure), SARS-CoV-2 was detected in pulmonary pneumocytes and ciliated airway cells (N = 5), and in upper airway epithelium (N = 2). In two patients with organizing DAD (>14 days from onset of respiratory failure), no virus was detected in lungs or airways. No endothelial cell infection was observed. The findings suggest that SARS-CoV-2 infection of epithelial cells in lungs and airways of patients with COVID-19 who developed respiratory failure can be detected during the acute phase of lung injury and is absent in the organizing phase.
C1 [Schaefer, Inga-Marie; Padera, Robert F.; Solomon, Isaac H.; Hornick, Jason L.; Sholl, Lynette M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Harvard Med Sch, Dept Populat Med, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Harvard Pilgrim Healthcare Inst, Boston, MA, United States.
   [Hammer, Mark M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115, United States.
C3 Harvard University; Brigham & Women's Hospital; Harvard Medical School;
   Harvard University; Brigham & Women's Hospital; Harvard University;
   Harvard Medical School; Harvard Pilgrim Health Care; Harvard University;
   Brigham & Women's Hospital; Harvard Medical School
RP Sholl, LM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
EM lmsholl@bwh.harvard.edu
RI Schaefer, Inga-Marie/ABA-3951-2020; Hammer, Mark/AAR-9625-2020
OI Schaefer, Inga-Marie/0000-0001-9710-5500; Hammer,
   Mark/0000-0002-1700-7984; Kanjilal, Sanjat/0000-0002-1221-5725; Padera,
   Robert/0000-0002-4571-5494; Solomon, Isaac/0000-0003-3432-0902
FU US National Institutes of Health (NIH/NCI) [K08-CA241085]; PhAST
   Diagnostics; Roche/Genentech
FX IMS was funded by US National Institutes of Health (NIH/NCI grant
   K08-CA241085). SK received funding support from PhAST Diagnostics. JLH
   is a consultant to Epizyme, Eli Lilly, Aadi Bioscience, and TRACON
   Pharmaceuticals. LMS reports consulting fees/honoraria from LOXO
   Oncology, EMD Serono, Foghorn Therapeutics, and Astra Zeneca and
   research funding to the institution from Roche/Genentech. The remaining
   authors have no conflicts to disclose.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]
   Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]
   Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776
   Coy S, 2016, MODERN PATHOL, V29, P1446, DOI 10.1038/modpathol.2016.153
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Harenberg J, 2020, CLIN CHEM LAB MED, V58, P1029, DOI 10.1515/cclm-2020-0502
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Li Y, 2020, EUR RADIOL, V30, P6186, DOI 10.1007/s00330-020-06969-5
   LONG QX, 2020, NAT MED, V26, P845, DOI [DOI 10.1038/S41591-020-0897-1, 10.1101/2020.03.18.20038018]
   Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X
   Martines RB, 2020, EMERG INFECT DIS, V26, P2005, DOI 10.3201/eid2609.202095
   Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]
   Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027
   Ottestad William, 2020, Tidsskr Nor Laegeforen, V140, DOI 10.4045/tidsskr.20.0299
   Pujadas E, 2020, J MED VIROL, V92, P1695, DOI 10.1002/jmv.25988
   Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wilkerson RG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.044
   Wu CA, 2008, AM J PATHOL, V172, P714, DOI 10.2353/ajpath.2008.070462
   Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang Xiaobo, 2020, Lancet Respir Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533
   Zhao R, 2020, CLIN INFECT DIS
NR 36
TC 190
Z9 194
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0893-3952
EI 1530-0285
J9 MODERN PATHOL
JI Mod. Pathol.
PD NOV
PY 2020
VL 33
IS 11
BP 2104
EP 2114
DI 10.1038/s41379-020-0595-z
EA JUN 2020
PG 11
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA OF2UZ
UT WOS:000541317200002
PM 32561849
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Silva, JD
   Su, Y
   Calfee, CS
   Delucchi, KL
   Weiss, D
   McAuley, DF
   O'Kane, C
   Krasnodembskaya, AD
AF Silva, Johnatas Dutra
   Su, Yue
   Calfee, Carolyn S.
   Delucchi, Kevin L.
   Weiss, Daniel
   McAuley, Danny F.
   O'Kane, Cecilia M.
   Krasnodembskaya, Anna D.
TI Mesenchymal stromal cell extracellular vesicles rescue mitochondrial
   dysfunction and improve barrier integrity in clinically relevant models
   of ARDS
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; PLASMA ANGIOPOIETIN-2;
   STEM-CELLS; MICROVESICLES; SUBPHENOTYPES; VALIDATION; REPAIR
AB Alveolar epithelial-capillary barrier disruption is a hallmark of acute respiratory distress syndrome (ARDS). Contribution of mitochondrial dysfunction to the compromised alveolar-capillary barrier in ARDS remains unclear. Mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) are considered as a cell-free therapy for ARDS. Mitochondrial transfer was shown to be important for the therapeutic effects of MSCs and MSC-EVs. Here we investigated the contribution of mitochondrial dysfunction to the injury of alveolar epithelial and endothelial barriers in ARDS and the ability of MSC-EVs to modulate alveolar-capillary barrier integrity through mitochondrial transfer.
   Primary human small airway epithelial and pulmonary microvascular endothelial cells and human precision cut lung slices (PCLSs) were stimulated with endotoxin or plasma samples from patients with ARDS and treated with MSC-EVs, barrier properties and mitochondrial functions were evaluated. Lipopolysaccharide (LPS)-injured mice were treated with MSC-EVs and degree of lung injury and mitochondrial respiration of the lung tissue were assessed.
   Inflammatory stimulation resulted in increased permeability coupled with pronounced mitochondrial dysfunction in both types of primary cells and PCLSs. Extracellular vesicles derived from normal MSCs restored barrier integrity and normal levels of oxidative phosphorylation while an extracellular vesicles preparation which did not contain mitochondria was not effective. In vivo, presence of mitochondria was critical for extracellular vesicles ability to reduce lung injury and restore mitochondrial respiration in the lung tissue.
   In the ARDS environment, MSC-EVs improve alveolar-capillary barrier properties through restoration of mitochondrial functions at least partially via mitochondrial transfer.
C1 [Silva, Johnatas Dutra; Su, Yue; McAuley, Danny F.; O'Kane, Cecilia; Krasnodembskaya, Anna D.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland, United Kingdom.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143, United States.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA, United States.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA, United States.
   [Delucchi, Kevin L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA, United States.
   [Weiss, Daniel] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT, United States.
C3 Queens University Belfast; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of Vermont
RP Krasnodembskaya, AD (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.
EM a.krasnodembskaya@qub.ac.uk
RI Silva, Johnatas D/I-6478-2017; Krasnodembskaya, Anna/I-1225-2019
OI Silva, Johnatas D/0000-0003-4379-4237; Krasnodembskaya,
   Anna/0000-0002-2380-5069; McAuley, Daniel/0000-0002-3283-1947
FU UK Medical Research Council [MRC MR/R025096/1, MR/S009426/1]; MRC
   [MR/S009426/1, MR/R025096/1] Funding Source: UKRI
FX This work was supported by UK Medical Research Council Research Awards
   (MRC MR/R025096/1 and MR/S009426/1 - to AK) . Funding information for
   this article has been deposited with the Crossref Funder Registry.
CR Abraham A, 2020, STEM CELL TRANSL MED, V9, P28, DOI 10.1002/sctm.19-0205
   Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC
   Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Apostolova N, 2015, ANTIOXID REDOX SIGN, V22, P686, DOI 10.1089/ars.2014.5952
   Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494
   Biswas S, 2013, CURR MED CHEM, V20, P1496, DOI 10.2174/0929867311320120004
   Bos LD, 2017, THORAX, V72, P876, DOI 10.1136/thoraxjnl-2016-209719
   Bos LDJ, 2019, AM J RESP CRIT CARE, V200, P42, DOI 10.1164/rccm.201809-1808OC
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87
   Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC
   Cho HY, 2020, ARCH PHARM RES, V43, P297, DOI 10.1007/s12272-019-01182-5
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dushianthan A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012041.pub2
   Elahi FM, 2020, STEM CELLS, V38, P15, DOI 10.1002/stem.3061
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Fergie N, 2019, FASEB J, V33, P5585, DOI 10.1096/fj.201802056R
   Hao Q, 2019, J IMMUNOL, V203, P1961, DOI 10.4049/jimmunol.1801534
   Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc
   Hough RF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124329
   Hu SL, 2018, STEM CELL TRANSL MED, V7, P615, DOI 10.1002/sctm.17-0278
   Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372
   Kozlov AV, 2017, REDOX BIOL, V13, P170, DOI 10.1016/j.redox.2017.05.017
   Laffey JG, 2018, LANCET RESP MED, V6, P659, DOI 10.1016/S2213-2600(18)30279-0
   Lee JH, 2019, TRANSFUSION, V59, P876, DOI 10.1111/trf.14838
   Lentz SI, 2010, J HISTOCHEM CYTOCHEM, V58, P207, DOI 10.1369/jhc.2009.954701
   Lewis SR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004477.pub3
   Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19
   Mahida RY, 2020, AM J RESP CELL MOL, V63, P15, DOI 10.1165/rcmb.2019-0447TR
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC
   Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC
   Parikh SM, 2017, CURR OPIN HEMATOL, V24, P432, DOI 10.1097/MOH.0000000000000361
   Park J, 2019, THORAX, V74, P43, DOI 10.1136/thoraxjnl-2018-211576
   Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575
   Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472
   Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322
   Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601
   Riou M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051253
   Ryter SW, 2018, ANN AM THORAC SOC, V15, pS266, DOI 10.1513/AnnalsATS.201808-585MG
   Silva JD, 2020, CYTOTHERAPY, V22, pS25
   Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100
   Supinski GS, 2020, CHEST, V157, P310, DOI 10.1016/j.chest.2019.08.2182
   Tang XD, 2017, STEM CELLS, V35, P1849, DOI 10.1002/stem.2619
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Uhl FE, 2015, EUR RESPIR J, V46, P1150, DOI 10.1183/09031936.00183214
   Varkouhi AK, 2019, ANESTHESIOLOGY, V130, P778, DOI 10.1097/ALN.0000000000002655
   Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521
   Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504
   Zinter MS, 2016, AM J PHYSIOL-LUNG C, V310, pL224, DOI 10.1152/ajplung.00336.2015
NR 56
TC 56
Z9 56
U1 6
U2 24
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD JUL 1
PY 2021
VL 58
IS 1
AR 2002978
DI 10.1183/13993003.02978-2020
PG 18
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA TH3KJ
UT WOS:000671991400006
PM 33334945
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Smadja, DM
   Mentzer, SJ
   Fontenay, M
   Laffan, MA
   Ackermann, M
   Helms, J
   Jonigk, D
   Chocron, R
   Pier, GB
   Gendron, N
   Pons, S
   Diehl, JL
   Margadant, C
   Guerin, C
   Huijbers, EJM
   Philippe, A
   Chapuis, N
   Nowak-Sliwinska, P
   Karagiannidis, C
   Sanchez, O
   Kumpers, P
   Skurnik, D
   Randi, AM
   Griffioen, AW
AF Smadja, David M.
   Mentzer, Steven J.
   Fontenay, Michaela
   Laffan, Mike A.
   Ackermann, Maximilian
   Helms, Julie
   Jonigk, Danny
   Chocron, Richard
   Pier, Gerald B.
   Gendron, Nicolas
   Pons, Stephanie
   Diehl, Jean-Luc
   Margadant, Coert
   Guerin, Coralie
   Huijbers, Elisabeth J. M.
   Philippe, Aurelien
   Chapuis, Nicolas
   Nowak-Sliwinska, Patrycja
   Karagiannidis, Christian
   Sanchez, Olivier
   Kuempers, Philipp
   Skurnik, David
   Randi, Anna M.
   Griffioen, Arjan W.
TI COVID-19 is a systemic vascular hemopathy: insight for mechanistic and
   clinical aspects
SO ANGIOGENESIS
LA English
DT Review
ID VON-WILLEBRAND-FACTOR; HEMATOPOIETIC STEM-CELLS; DISSEMINATED
   INTRAVASCULAR COAGULATION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SEPTIC
   SHOCK; SUBLINGUAL MICROCIRCULATION; ENDOTHELIAL GLYCOCALYX; CONVALESCENT
   PLASMA; POSTMORTEM FINDINGS; TISSUE DISTRIBUTION
AB Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 beta [IL-1 beta] or IL-6), several main pathological phenomena have been seen because of endothelial cell (EC) dysfunction: hypercoagulation reflected by fibrin degradation products called D-dimers, micro- and macrothrombosis and pathological angiogenesis. Direct endothelial infection by SARS-CoV-2 is not likely to occur and ACE-2 expression by EC is a matter of debate. Indeed, endothelial damage reported in severely ill patients with COVID-19 could be more likely secondary to infection of neighboring cells and/or a consequence of inflammation. Endotheliopathy could give rise to hypercoagulation by alteration in the levels of different factors such as von Willebrand factor. Other than thrombotic events, pathological angiogenesis is among the recent findings. Overexpression of different proangiogenic factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF-2) or placental growth factors (PlGF) have been found in plasma or lung biopsies of COVID-19 patients. Finally, SARS-CoV-2 infection induces an emergency myelopoiesis associated to deregulated immunity and mobilization of endothelial progenitor cells, leading to features of acquired hematological malignancies or cardiovascular disease, which are discussed in this review. Altogether, this review will try to elucidate the pathophysiology of thrombotic complications, pathological angiogenesis and EC dysfunction, allowing better insight in new targets and antithrombotic protocols to better address vascular system dysfunction. Since treating SARS-CoV-2 infection and its potential long-term effects involves targeting the vascular compartment and/or mobilization of immature immune cells, we propose to define COVID-19 and its complications as a systemic vascular acquired hemopathy.
C1 [Smadja, David M.; Gendron, Nicolas; Diehl, Jean-Luc; Guerin, Coralie; Philippe, Aurelien] Univ Paris, Innovat Therapies Haemostasis, INSERM, Paris, France.
   [Smadja, David M.; Gendron, Nicolas; Philippe, Aurelien] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Hematol, Carpentier Fdn, Paris, France.
   [Smadja, David M.; Gendron, Nicolas; Philippe, Aurelien] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.
   [Smadja, David M.; Ackermann, Maximilian; Jonigk, Danny; Sanchez, Olivier] F CRIN INNOVTE Network, Paris, France.
   [Mentzer, Steven J.] Harvard Med Sch, Euro Amer COVID 19 Working Grp, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Mentzer, Steven J.] Harvard Med Sch, Lab Adapt & Regenerat Biol, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Fontenay, Michaela; Gendron, Nicolas] Univ Paris, Inst Cochin, INSERM, Paris, France.
   [Fontenay, Michaela; Jonigk, Danny; Gendron, Nicolas] Assistance Publ Hop Paris, Dept Hematol, Paris, France.
   [Laffan, Mike A.] Imperial Coll London, Ctr Hematol, London, England, United Kingdom.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Euro Amer COVID 19 Working Grp, Witten, Germany.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Inst Pathol, Witten, Germany.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Dept Mol Pathol, Witten, Germany.
   [Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Inst Funct & Clin Anat, Univ Med Ctr, Mainz, Germany.
   [Helms, Julie] Hop Univ Strasbourg, Serv Med Intens Reanimat, Nouvel Hop Civil, Strasbourg, France.
   [Helms, Julie] Univ Strasbourg UNISTRA, INSERM UMR S1109, LabEx TRANSPLANTEX, Ctr Rech Immunol & Hematol,Fac Med,Federat Hosp U, Strasbourg, France.
   [Jonigk, Danny] Biomed Res Endstage & Obstruct Lung Dis Hannover, German Ctr Lung Res, Hannover, Germany.
   [Chocron, Richard] Univ Paris, PARCC, INSERM, Paris, France.
   [Chocron, Richard] Assistance Publ Hop Paris, Emergency Dept, Paris, France.
   [Pier, Gerald B.; Skurnik, David] Harvard Med Sch, Div Infect Dis, Dept Med, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Pons, Stephanie] Pitie Salpetriere Univ Hosp, Assistance Publ Hop Paris, Dept Anesthesiol & Crit Care, Paris, France.
   [Diehl, Jean-Luc] Assistance Publ Hop Paris, Intens Care Unit, Carpentier Fdn, Paris, France.
   [Diehl, Jean-Luc; Sanchez, Olivier] Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.
   [Margadant, Coert; Huijbers, Elisabeth J. M.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Angiogenesis Lab, Dept Med Oncol,Canc Ctr Amsterdam, Amsterdam, Netherlands.
   [Guerin, Coralie] Inst Curie, Cytometry Platform, Paris, France.
   [Nowak-Sliwinska, Patrycja] Univ Geneva, Sch Pharmaceut Sci, Mol Pharmacol Grp, Geneva, Switzerland.
   [Nowak-Sliwinska, Patrycja] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.
   [Karagiannidis, Christian] Univ Witten Herdecke, ARDS & ECMO Ctr Cologne Merheim, Cologne, Germany.
   [Sanchez, Olivier] Assistance Publ Hop Paris, Dept Resp Dis, Carpentier Fdn, Paris, France.
   [Kuempers, Philipp] Univ Hosp Munster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, Munster, Germany.
   [Skurnik, David] Univ Paris, INSERM, F-75015 Paris, France.
   [Skurnik, David] Assistance Publ Hop Paris, Dept Microbiol, Paris, France.
   [Randi, Anna M.] Imperial Coll London, Natl Heart & Lung Inst, London, England, United Kingdom.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   UDICE-French Research Universities; Universite Paris Cite; UDICE-French
   Research Universities; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP;
   Universite Paris Cite; Hopital Universitaire Europeen Georges-Pompidou -
   APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Universite Paris
   Cite; Hopital Universitaire Europeen Georges-Pompidou - APHP; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Universite Paris
   Cite; Hopital Universitaire Robert-Debre - APHP; Imperial College
   London; Witten Herdecke University; Witten Herdecke University; Witten
   Herdecke University; Johannes Gutenberg University of Mainz; CHU
   Strasbourg; UDICE-French Research Universities; Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Harvard University;
   Brigham & Women's Hospital; Harvard Medical School; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   UDICE-French Research Universities; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Sorbonne Universite; Hopital
   Universitaire Saint-Antoine - APHP; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; University of Amsterdam; Vrije
   Universiteit Amsterdam; UDICE-French Research Universities; Universite
   PSL; UNICANCER; Institut Curie; University of Geneva; University of
   Geneva; Witten Herdecke University; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; University of Munster; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Imperial College
   London
RP Smadja, DM (corresponding author), Univ Paris, Innovat Therapies Haemostasis, INSERM, Paris, France.; Smadja, DM (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Hematol, Carpentier Fdn, Paris, France.; Smadja, DM (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.; Smadja, DM (corresponding author), F CRIN INNOVTE Network, Paris, France.
EM david.smadja@aphp.fr
RI Pons, Stephanie/IRZ-9466-2023; Randi, Anna/HLP-5457-2023; Guerin,
   Coralie/HKV-6282-2023; Nowak-Sliwinska, Patrycja/T-7663-2018; Chapuis,
   nicolas/HIR-3009-2022; Gendron, Nicolas/AAB-8014-2022; Chocron,
   Richard/ABF-5825-2021
OI Nowak-Sliwinska, Patrycja/0000-0002-8299-0444; Chapuis,
   nicolas/0000-0003-0601-3948; Gendron, Nicolas/0000-0003-4852-4738; Pons,
   Stephanie/0000-0002-7372-3563; Skurnik, David/0000-0002-4205-9639;
   Guerin, Coralie/0000-0002-1840-4017; Laffan, Michael/0000-0002-8268-3268
FU French national agency for research ANR Flash-COVID SARCODO (Fondation
   de France); ANR AAP RA-COVID-19 VASCOV (CAPNET label "priorite nationale
   de recherche" by French Government); Mecenat Covid AP-HP; SARCODO-EP
   (Contrat de recherche clinique DRCI AP-HP) [COV21033]; French national
   agency for research ANR AAP RA-COVID-19 CALPRO; Site de Recherche
   Integre sur le Cancer CARPEM of the Institut National du Cancer; Dutch
   Cancer Society [KWF2018-11651]; European Research Council (ERC)
   [680209]; Swiss National Science Foundation [310030-197878]; British
   Heart Foundation (BHF); Imperial College COVID response Fund; Swiss
   National Science Foundation (SNF) [310030_197878] Funding Source: Swiss
   National Science Foundation (SNF); European Research Council (ERC)
   [680209] Funding Source: European Research Council (ERC)
FX We thank Maud BARRANDON for Fig. 1 design. DM SMADJA, O SANCHEZ and JL
   DIEHL are funded with grants from French national agency for research
   ANR Flash-COVID SARCODO (Fondation de France), ANR AAP RA-COVID-19
   VASCOV (CAPNET label "priorite nationale de recherche" by French
   Government), Mecenat Covid AP-HP and SARCODO-EP (COV21033-Contrat de
   recherche clinique DRCI AP-HP). M FONTENAY work is funded by the French
   national agency for research ANR AAP RA-COVID-19 CALPRO, the Mecenat
   Covid AP-HP and the Site de Recherche Integre sur le Cancer CARPEM of
   the Institut National du Cancer. AW GRIFFIOEN and EJM HUIJBERS are
   funded by the Dutch Cancer Society (KWF2018-11651). P NOWAK-SLIWINSKA is
   funded by the European Research Council (ERC-680209) and by the Swiss
   National Science Foundation (#310030-197878). AM RANDI is funded by the
   British Heart Foundation (BHF) and the Imperial College COVID response
   Fund.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P888, DOI 10.1056/NEJMc2022068
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429
   AMADOAZEVEDO J, 2021, ANGIOGENESIS
   Aman J, 2021, IN PRESS
   Amrun SN, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102911
   Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359
   [Anonymous], 2020, BMJ, V371, pm4232, DOI 10.1136/bmj.m4232
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   Arachchillage DJ, 2020, BRIT J HAEMATOL, V190, pE270, DOI 10.1111/bjh.17050
   Arachchillage DRJ, 2021, SEMIN THROMB HEMOST, V47, P436, DOI 10.1055/s-0040-1722309
   Bajou K, 2014, NAT MED, V20, P741, DOI 10.1038/nm.3552
   Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135
   Barrett TJ, 2020, CIRC RES, V127, P945, DOI 10.1161/CIRCRESAHA.120.317803
   Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556
   Bassler K, 2019, ANNU REV IMMUNOL, V37, P269, DOI 10.1146/annurev-immunol-042718-041728
   Bazzan M, 2020, INTERN EMERG MED, V15, P861, DOI 10.1007/s11739-020-02394-0
   Beenen LFM, 2020, THROMB RES, V196, P135, DOI 10.1016/j.thromres.2020.08.026
   Beloncle FM, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00675-7
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Bermejo-Martin JF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03398-0
   Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Blasi A, 2020, J THROMB HAEMOST, V18, P2646, DOI 10.1111/jth.15043
   Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004
   Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253
   Bolton Kelly L, 2020, medRxiv, DOI [10.1038/s41467-021-26138-6, 10.1101/2020.11.25.20233163]
   BORGEL D, 2021, CRIT CARE
   Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF
   Buijsers B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575047
   Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242
   Byzova TV, 2016, BLOOD, V128, P2283, DOI 10.1182/blood-2016-09-737023
   Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005
   CADUFF JH, 1986, ANAT RECORD, V216, P154, DOI 10.1002/ar.1092160207
   Cai ZG, 2018, CELL STEM CELL, V23, P833, DOI 10.1016/j.stem.2018.10.013
   Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Carsetti A, 2020, MICROVASC RES, V132, DOI 10.1016/j.mvr.2020.104064
   Casadevall A, 2020, J CLIN INVEST, V130, P5112, DOI 10.1172/JCI139760
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Caviedes I, 2021, AM J RESP CRIT CARE, V203, P258, DOI 10.1164/rccm.202009-3446LE
   Chapman DG, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03263-2020
   Chavkin NW, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00042
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen LT, 2020, CELL MOL IMMUNOL, V17, P992, DOI 10.1038/s41423-020-0492-x
   Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580
   Cheng PY, 2019, LEUKEMIA, V33, P2034, DOI 10.1038/s41375-019-0397-9
   Chiumello D, 2020, INTENS CARE MED, V46, P2187, DOI 10.1007/s00134-020-06281-2
   CHOCRON R, 2021, ARCH CARDIOVASC DIS
   Chocron R, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018624
   Chun SH, 2021, EUR RADIOL, V31, P1130, DOI 10.1007/s00330-020-07173-1
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Couzin-Frankel J, 2020, SCIENCE, V368, P455, DOI 10.1126/science.368.6490.455
   Damiani E, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00680-w
   Darcy CJ, 2014, CRIT CARE, V18, DOI 10.1186/cc14003
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   Romualdo LGD, 2021, J INFECTION, V82, pE40, DOI 10.1016/j.jinf.2020.08.010
   Debuc B, 2021, STEM CELL REV REP, V17, P4, DOI 10.1007/s12015-020-09987-4
   Delabranche X, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0339-5
   Delabranche X, 2016, CRIT CARE MED, V44, pE930, DOI 10.1097/CCM.0000000000001836
   Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650
   Dhawan RT, 2021, LANCET RESP MED, V9, P107, DOI 10.1016/S2213-2600(20)30407-0
   Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5
   Diehl JL, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00757-6
   Diehl JL, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00716-1
   Santo DAD, 2020, J THROMB THROMBOLYS, V50, P790, DOI 10.1007/s11239-020-02245-x
   Doevelaar AAN, 2021, CRIT CARE MED, V49, pE512, DOI 10.1097/CCM.0000000000004918
   Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844
   Drost CC, 2019, THROMB HAEMOSTASIS, V119, P1827, DOI 10.1055/s-0039-1695768
   Duployez N, 2020, CANCERS, V12, DOI 10.3390/cancers12071992
   Dupont A, 2021, ARTERIOSCL THROM VAS, V41, P1760, DOI 10.1161/ATVBAHA.120.315595
   Dupont V, 2021, CLIN INFECT DIS, V72, P1834, DOI 10.1093/cid/ciaa1007
   Dutt T, 2021, BLOOD, V137, P1731, DOI 10.1182/blood.2020007599
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Escher R, 2020, THROMB RES, V192, P174, DOI 10.1016/j.thromres.2020.05.032
   Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815
   Fakhr BS, 2020, BRIT J ANAESTH, V125, pE434, DOI 10.1016/j.bja.2020.08.001
   Falasca L, 2020, J INFECT DIS, V222, P1807, DOI 10.1093/infdis/jiaa578
   Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1
   Filipovic N, 2009, MICROVASC RES, V78, P286, DOI 10.1016/j.mvr.2009.08.004
   Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Fraser Douglas D, 2020, Crit Care Explor, V2, pe0144, DOI 10.1097/CCE.0000000000000144
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gendron N, 2021, ARTHRITIS RHEUMATOL, V73, P1976, DOI 10.1002/art.41777
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Giardini V, 2020, AM J HEMATOL, V95, pE188, DOI 10.1002/ajh.25882
   Goldsmith CS, 2020, LANCET, V395, pE99, DOI 10.1016/S0140-6736(20)31188-0
   Goligher EC, 2021, INTENS CARE MED, V47, P83, DOI 10.1007/s00134-020-06320-y
   Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7
   Goudot G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.586307
   Gowd V, 2016, WORLD J DIABETES, V7, P67, DOI 10.4239/wjd.v7.i4.67
   GREENE R, 1987, AM J ROENTGENOL, V148, P501, DOI 10.2214/ajr.148.3.501
   Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840
   Griffioen AW, 2000, PHARMACOL REV, V52, P237
   Grimmer B, 2017, J APPL PHYSIOL, V123, P1635, DOI 10.1152/japplphysiol.00120.2017
   Gue YX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091850
   Guerin CL, 2021, STEM CELL REV REP, V17, P639, DOI 10.1007/s12015-020-10062-1
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013
   Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hakanpaa L, 2018, P NATL ACAD SCI USA, V115, pE6467, DOI 10.1073/pnas.1722317115
   Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hardman N, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13264
   Hattori N, 1999, AM J PHYSIOL-LUNG C, V277, pL573, DOI 10.1152/ajplung.1999.277.3.L573
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Helms J, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00809-5
   Helms J, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00704-5
   Helms J, 2020, INTENS CARE MED, V46, P1502, DOI 10.1007/s00134-020-06082-7
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693
   Herrmann J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18672-6
   Hu WT, 2020, EMERG INFECT DIS, V26, P2974, DOI 10.3201/eid2612.203334
   Hueso T, 2020, BLOOD, V136, P2290, DOI 10.1182/blood.2020008423
   Huijbers EJM, 2018, VACCINE, V36, P3054, DOI 10.1016/j.vaccine.2018.03.064
   Huijbers EJM, 2017, HUM VACC IMMUNOTHER, V13, P1112, DOI 10.1080/21645515.2016.1276140
   Iba T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1468-1
   IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217
   Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Jonigk D, 2021, INTENS CARE MED, V47, P86, DOI 10.1007/s00134-020-06302-0
   Jonmarker S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03375-7
   Kandalla PK, 2016, J EXP MED, V213, P2269, DOI 10.1084/jem.20151975
   Edul VSK, 2021, J CRIT CARE, V61, P73, DOI 10.1016/j.jcrc.2020.10.002
   Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7
   Karmaus PWF, 2017, J EXP MED, V214, P2629, DOI 10.1084/jem.20161855
   Karuppan MKM, 2021, MOL NEUROBIOL, V58, P2465, DOI 10.1007/s12035-020-02245-1
   KAWANO Y, 1991, BLOOD, V77, P2118
   Khider L, 2020, J THROMB HAEMOST, V18, P2391, DOI 10.1111/jth.14968
   Khinda J, 2021, J MED VIROL, V93, P1078, DOI 10.1002/jmv.26411
   Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873
   Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
   Kong YX, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03079-y
   Kraakman MJ, 2017, J CLIN INVEST, V127, P2133, DOI 10.1172/JCI92450
   Kruse JM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03401-8
   Kumpers P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1978-0
   Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130
   Kwaan HC, 2011, SEMIN THROMB HEMOST, V37, P960, DOI 10.1055/s-0031-1297375
   Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Lee D. -H., 2014, PLOS ONE, V9
   Lee GS, 2011, DEV DYNAM, V240, P1335, DOI 10.1002/dvdy.22618
   Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706
   Leimkuhler NB, 2021, CELL STEM CELL, V28, P637, DOI 10.1016/j.stem.2020.11.004
   Leppkes M, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102925
   Lerum TV, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03448-2020
   Li LL, 2021, J INFECT DIS, V223, P178, DOI 10.1093/infdis/jiaa642
   Liepelt A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010127
   Liu J, 2011, BLOOD, V117, P342, DOI 10.1182/blood-2010-06-287987
   LONG QX, 2020, NAT MED, V26, P845, DOI [DOI 10.1038/S41591-020-0897-1, 10.1101/2020.03.18.20038018]
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   LUO Y, 2020, CLIN INFECT DIS, V10, P2
   Lynch KL, 2021, CLIN INFECT DIS, V72, P301, DOI 10.1093/cid/ciaa979
   Maatman TK, 2020, CRIT CARE MED, V48, pE783, DOI 10.1097/CCM.0000000000004466
   Makowski L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020146
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mancini I, 2021, J THROMB HAEMOST, V19, P513, DOI 10.1111/jth.15191
   Mancuso P, 2020, J THROMB HAEMOST, V18, P2744, DOI 10.1111/jth.15044
   Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197
   Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660
   Mauri T, 2020, CRIT CARE MED, V48, P1129, DOI 10.1097/CCM.0000000000004386
   Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
   McAndrews KM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142386
   McCormack JJ, 2017, J CELL SCI, V130, P3611, DOI 10.1242/jcs.208033
   McCracken IR, 2021, CIRCULATION, V143, P865, DOI 10.1161/CIRCULATIONAHA.120.052824
   Medcalf RL, 2020, J THROMB HAEMOST, V18, P2118, DOI 10.1111/jth.14960
   Meduri GU, 2009, CHEST, V136, P1631, DOI 10.1378/chest.08-2408
   Meghraoui-Kheddar A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01117
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Meizlish ML, 2021, AM J HEMATOL, V96, P471, DOI [10.1002/ajh.26102, 10.1101/2021.01.12.21249577]
   Meizlish Matthew L, 2020, medRxiv, DOI 10.1101/2020.06.29.20140376
   Mendoza M, 2020, BJOG-INT J OBSTET GY, V127, P1374, DOI 10.1111/1471-0528.16339
   Mengos AE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01147
   Mentzer SJ, 2014, ANGIOGENESIS, V17, P499, DOI 10.1007/s10456-014-9428-3
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Miller SE, 2020, NEW ENGL J MED, V383, P2689, DOI 10.1056/NEJMc2030450
   Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034
   Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571
   Mo XN, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01217-2020
   Monneret G, 2016, CYTOM PART B-CLIN CY, V90, P376, DOI 10.1002/cyto.b.21270
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008
   Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029
   Negro A, 2021, AM J HEMATOL, V96, pE41, DOI 10.1002/ajh.26037
   Noh JY, 2020, J INFECTION, V81, P816, DOI 10.1016/j.jinf.2020.05.035
   Nolte MA, 2021, TRENDS BIOCHEM SCI, V46, P124, DOI 10.1016/j.tibs.2020.09.001
   Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116
   Nougier C, 2020, J THROMB HAEMOST, V18, P2215, DOI 10.1111/jth.15016
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   O'Sullivan JM, 2020, BRIT J HAEMATOL, V190, P27, DOI 10.1111/bjh.16845
   Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342
   Ospina-Tascon GA, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00651-1
   Oudemans-van Straaten HM, 2015, SEMIN THROMB HEMOST, V41, P91, DOI 10.1055/s-0034-1398384
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645
   Paschall AV, 2015, J IMMUNOL, V194, P2369, DOI 10.4049/jimmunol.1402412
   Patel BV, 2020, AM J RESP CRIT CARE, V202, P690, DOI 10.1164/rccm.202004-1412OC
   Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]
   Philippe A, 2021, ANGIOGENESIS, V24, P505, DOI 10.1007/s10456-020-09762-6
   Phipps WS, 2020, AM J CLIN PATHOL, V154, P459, DOI 10.1093/ajcp/aqaa123
   Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346
   Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003
   Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043
   Planquette B, 2021, THROMB RES, V197, P94, DOI 10.1016/j.thromres.2020.11.001
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Polidoro RB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01626
   Potje SR, 2021, LIFE SCI, V276, DOI 10.1016/j.lfs.2021.119376
   Psaila B, 2019, BLOOD, V133, P1427, DOI 10.1182/blood-2018-11-835371
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489
   Rahimi A, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05242-4
   Ramjiawan RR, 2017, ANGIOGENESIS, V20, P185, DOI 10.1007/s10456-017-9552-y
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Ratajczak MZ, 2017, CIRC RES, V120, P166, DOI 10.1161/CIRCRESAHA.116.309362
   Rauch A, 2020, CIRCULATION, V142, P1881, DOI 10.1161/CIRCULATIONAHA.120.050907
   Reglero-Real N, 2016, ARTERIOSCL THROM VAS, V36, P2048, DOI 10.1161/ATVBAHA.116.307610
   Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5
   Ren LL, 2021, CLIN INFECT DIS, V72, pE545, DOI 10.1093/cid/ciaa1247
   Reyes Miguel, 2020, bioRxiv, DOI 10.1101/2020.09.02.280180
   Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4
   Rodriguez MR, 2021, INT J LAB HEMATOL, V43, pE152, DOI 10.1111/ijlh.13476
   Roncati L, 2020, PLATELETS, V31, P1085, DOI 10.1080/09537104.2020.1810224
   Rovas A, 2021, ANGIOGENESIS, V24, P145, DOI 10.1007/s10456-020-09753-7
   Rovas A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2542-2
   Sack KD, 2020, CRIT CARE CLIN, V36, P201, DOI 10.1016/j.ccc.2019.12.003
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Salem S, 2020, GLOB MID EAST, P1, DOI [10.2214/AJR.20.23034, 10.1017/9781108868969, 10.2214/AJR.20.23034S.]
   Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474
   Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047
   Schurch CM, 2014, CELL STEM CELL, V14, P460, DOI 10.1016/j.stem.2014.01.002
   Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001
   Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665
   Sella N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03242-5
   Shah A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03260-3
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434
   Shi H, 2021, J LEUKOCYTE BIOL, V109, P67, DOI [10.1002/JLB.3COVCRA0720-359R, 10.1101/2020.05.06.20093070]
   Si-Mohamed S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02608-2020
   Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002
   Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304
   Sinha P, 2013, CRIT CARE, V17, DOI 10.1186/cc12541
   Slessarev M, 2020, CAN J ANESTH, V67, P1288, DOI 10.1007/s12630-020-01661-0
   Smadja DM, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00956-2021
   Smadja DM, 2021, J THROMB HAEMOST, V19, P1823, DOI 10.1111/jth.15339
   Smadja DM, 2020, ANGIOGENESIS, V23, P611, DOI 10.1007/s10456-020-09730-0
   Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246
   Song JW, 2017, J PHARMACOL EXP THER, V361, P115, DOI 10.1124/jpet.116.239509
   Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018
   Sreejit G, 2020, CIRCULATION, V141, P1080, DOI 10.1161/CIRCULATIONAHA.119.043833
   Stahl K, 2020, AM J RESP CRIT CARE, V202, P1178, DOI 10.1164/rccm.202007-2676LE
   Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824
   Susen S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03000-7
   Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010
   Szwebel TA, 2021, STEM CELL REV REP, V17, P296, DOI 10.1007/s12015-020-10107-5
   Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]
   Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Thachil J, 2020, J THROMB HAEMOST, V18, P2138, DOI 10.1111/jth.15004
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP
   TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112
   Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726
   Turecek PL, 2021, THROMB RES, V201, P100, DOI 10.1016/j.thromres.2021.02.012
   Uchimido R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2292-6
   Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745
   Undas A, 2019, EXPERT REV HEMATOL, V12, P597, DOI 10.1080/17474086.2019.1627193
   Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002
   Valdivia-Mazeyra MF, 2021, VIRCHOWS ARCH, V478, P487, DOI 10.1007/s00428-020-02926-1
   van der Bijl I, 2020, MATRIX BIOL, V93, P60, DOI 10.1016/j.matbio.2020.05.005
   Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vassiliou AG, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010186
   Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03
   von Meijenfeldt FA, 2021, RES PRACT THROMB HAE, V5, P132, DOI 10.1002/rth2.12462
   Wang LM, 2012, J CLIN INVEST, V122, P4218, DOI 10.1172/JCI59176
   Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298
   Wang YQ, 2020, J CLIN INVEST, V130, P5235, DOI [10.1172/JCI138759, 10.1172/JCI138759.]
   Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268
   Weinbaum S, 2021, CARDIOVASC ENG TECHN, V12, P37, DOI 10.1007/s13239-020-00485-9
   Weiss E, 2020, THROMB HAEMOSTASIS, V120, P1343, DOI 10.1055/s-0040-1713637
   Whyte CS, 2020, J THROMB HAEMOST, V18, P1548, DOI 10.1111/jth.14872
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   WRIGHT F, 2020, J AM COLL SURGEONS
   Wu SC, 2021, BLOOD ADV, V5, P1305, DOI 10.1182/bloodadvances.2020003259
   Wu Y, 2020, QJM-INT J MED, V113, P539, DOI 10.1093/qjmed/hcaa121
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429
   Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801
   Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007
   Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029
   Yang Lu-Lu, 2020, Chronic Dis Transl Med, V6, P79, DOI 10.1016/j.cdtm.2020.05.002
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yau JW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0124-z
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252
   ZHANG R, 2020, J VASC SURG VENOUS L
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007
   Zhao JW, 2020, ADV POLYM SCI, V285, P1, DOI 10.1007/12_2020_62
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zheng L, 2016, BLOOD ADV, V1, P75, DOI 10.1182/bloodadvances.2016000711
   Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
   Zuo Yu, 2020, medRxiv, DOI 10.1101/2020.08.29.20184358
NR 313
TC 75
Z9 79
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD NOV
PY 2021
VL 24
IS 4
BP 755
EP 788
DI 10.1007/s10456-021-09805-6
EA JUN 2021
PG 34
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA WA6NV
UT WOS:000667636900001
PM 34184164
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Biancatelli, RMLC
   Solopov, PA
   Sharlow, ER
   Lazo, JS
   Marik, PE
   Catravas, JD
AF Biancatelli, Ruben M. L. Colunga
   Solopov, Pavel A.
   Sharlow, Elizabeth R.
   Lazo, John S.
   Marik, Paul E.
   Catravas, John D.
TI The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung
   injury in K18-hACE2 transgenic mice and barrier dysfunction in human
   endothelial cells
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
DE Acute kidney injury; COVID-19/SARS-CoV-2/Coronavirus; permeability; spike protein 
ID RESPIRATORY SYNDROME CORONAVIRUS; CONVERTING ENZYME; ENTRY;
   IDENTIFICATION; ACTIVATION; RECEPTOR; TMPRSS2; ACE2
AB Acute lung injury (ALI) leading to acute respiratory distress syndrome is the major cause of COVID-19 lethality. Cell entry of SARS-CoV-2 occurs via the interaction between its surface spike protein (SP) and angiotensin-converting enzyme-2 (ACE2). It is unknown if the viral spike protein alone is capable of altering lung vascular permeability in the lungs or producing lung injury in vivo. To that end, we intratracheally instilled the S1 subunit of SARS-CoV-2 spike protein (S1SP) in K18-hACE2 transgenic mice that overexpress human ACE2 and examined signs of COVID-19-associated lung injury 72 h later. Controls included K18-hACE2 mice that received saline or the intact SP and wild-type (WT) mice that received S1SP. K18-hACE2 mice instilled with S1SP exhibited a decline in body weight, dramatically increased white blood cells and protein concentrations in bronchoalveolar lavage fluid (BALF), upregulation of multiple inflammatory cytokines in BALF and serum, histological evidence of lung injury, and activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) pathways in the lung. K18-hACE2 mice that received either saline or SP exhibited little or no evidence of lung injury. WT mice that received S1SP exhibited a milder form of COVID-19 symptoms, compared with the K18-hACE2 mice. Furthermore, S1SP, but not SP, decreased cultured human pulmonary microvascular transendothelial resistance (TER) and barrier function. This is the first demonstration of a COVID-19-like response by an essential virus-encoded protein by SARS-CoV-2 in vivo. This model of COVID-19-induced ALI may assist in the investigation of new therapeutic approaches for the management of COVID-19 and other corona-viruses.
C1 [Biancatelli, Ruben M. L. Colunga; Solopov, Pavel A.; Catravas, John D.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23508, United States.
   [Sharlow, Elizabeth R.; Lazo, John S.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908, United States.
   [Marik, Paul E.; Catravas, John D.] Eastern Virginia Med Sch, Div Pulm Dis & Crit Care Med, Norfolk, VA 23501, United States.
   [Catravas, John D.] Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost & Translat Sci, Norfolk, VA 23508, United States.
C3 Old Dominion University; University of Virginia; Eastern Virginia
   Medical School; Old Dominion University
RP Catravas, JD (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23508 USA.; Catravas, JD (corresponding author), Eastern Virginia Med Sch, Div Pulm Dis & Crit Care Med, Norfolk, VA 23501 USA.; Catravas, JD (corresponding author), Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost & Translat Sci, Norfolk, VA 23508 USA.
EM jcatrava@odu.edu
RI Marik, Paul E/U-9733-2019
OI Solopov, Pavel/0000-0002-1705-027X; Catravas, John/0000-0002-5098-295X;
   Colunga Biancatelli, Ruben Manuel Luciano/0000-0002-1174-3876
FU Old Dominion Research Foundation; Fiske Drug Discovery Laboratory at the
   University of Virginia
FX This work was supported by the Old Dominion Research Foundation and the
   Fiske Drug Discovery Laboratory at the University of Virginia.
CR Asandei A, 2020, ACS APPL MATER INTER, V12, P55649, DOI 10.1021/acsami.0c17044
   Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y
   Barabutis N, 2018, J CELL MOL MED, V22, P1792, DOI 10.1111/jcmm.13460
   Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12
   Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11
   Catravas JD, 2010, VASC PHARMACOL, V52, P175, DOI 10.1016/j.vph.2009.12.009
   Dosch SF, 2009, VIRUS RES, V142, P19, DOI 10.1016/j.virusres.2009.01.005
   Gaddam Ravinder Reddy, 2014, Inflammation & Allergy Drug Targets, V13, P224
   Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   Horby P., 2020, NEW ENGL J MED, DOI [DOI 10.1056/NEJMOA2021436, 10.1056/NEJMoa2021436]
   Hsu AC-Y, 2020, SARS COV 2 SPIKE PRO, DOI [10.1101/2020.09.30.317818, DOI 10.1101/2020.09.30.317818]
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Karki Rajendra, 2020, bioRxiv, DOI [10.1016/j.cell.2020.11.025, 10.1101/2020.10.29.361048]
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lei YY, 2021, CIRC RES, V128, P1323, DOI 10.1161/CIRCRESAHA.121.318902
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Marinova M, 2019, INHAL TOXICOL, V31, P147, DOI 10.1080/08958378.2019.1624895
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111
   Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]
   Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7
   Ou XY, 2016, J VIROL, V90, P5586, DOI 10.1128/JVI.00015-16
   Rumende CM, 2020, ACTA MED INDONES, V52, P306
   Shirato K, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06187
   Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5
   Soldatov VO, 2020, RES RESULTS PHARM, V6, P1, DOI [10.3897/rrpharmacology. 6.53633, 10.3897/rrpharmacology.6.53633]
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2
   Yinda CK, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009195
   Zafer MM, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010159
   Zhou P, 2020, NATURE, V579, P270, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 32
TC 60
Z9 60
U1 2
U2 13
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD AUG
PY 2021
VL 321
IS 2
BP L477
EP L484
DI 10.1152/ajplung.00223.2021
PG 8
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA UM2DV
UT WOS:000693148000015
PM 34156871
OA Green Published
DA 2023-08-21
ER

PT J
AU Matthay, MA
   McAuley, DF
   Ware, LB
AF Matthay, Michael A.
   McAuley, Daniel Francis
   Ware, Lorraine B.
TI Clinical trials in acute respiratory distress syndrome: challenges and
   opportunities
SO LANCET RESPIRATORY MEDICINE
LA English
DT Review
ID ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; INTENSIVE-CARE UNITS;
   CELL-FREE HEMOGLOBIN; DEAD-SPACE FRACTION; STEM STROMAL CELLS;
   FLUID-MANAGEMENT; DOUBLE-BLIND; NEUROMUSCULAR BLOCKERS; RANDOMIZED-TRIAL
AB This year is the 50th anniversary of the first description of acute respiratory distress syndrome (ARDS). Since then, much has been learned about the pathogenesis of lung injury in ARDS, with an emphasis on the mechanisms of injury to the lung endothelium and the alveolar epithelium. In terms of treatment, major progress has been made in reducing mortality from ARDS with lung-protective ventilation, using a tidal volume of 6 mL per kg of predicted bodyweight and a plateau airway pressure of less than 30 cm H2O. In more severely hypoxaemic patients with ARDS, neuromuscular blockade and prone positioning have further reduced mortality, probably by extending the therapeutic effects of lung protective ventilation. Fluid-conservative therapy has also increased ventilator-free days in patients with ARDS. The lack of success of pharmacological therapies for ARDS, however, presents a continued challenge in the field. In addition to presenting a brief summary of previous experience with clinical trials in ARDS, we focus in this Review on future opportunities to improve clinical trial design to maximise the likelihood of identifying beneficial pharmacological therapies. In view of the heterogeneity in ARDS, both prognostic and predictive enrichment strategies are needed that target therapies toward specific subgroups of patients with ARDS on the basis of both severity and biology. Approaches to reducing heterogeneity in ARDS clinical trials include using physiological, radiographic, and biological criteria to select patients for both phase 2 and 3 trials. Additionally, interest is growing in the design of preventive clinical trials in ARDS and to initiate early treatment of patients with acute lung injury before the need for endotracheal intubation. We also present promising new approaches to treating ARDS, including combination therapies, cell-based therapies, and generic pharmacological compounds with low-risk profiles that are already in routine clinical use for other clinical indications.
C1 [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA, United States.
   [Matthay, Michael A.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA, United States.
   [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA, United States.
   [McAuley, Daniel F.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland, United Kingdom.
   [McAuley, Daniel F.] Belfast Hlth & Social Care Trust, Reg Intens Care Unit, Belfast, Antrim, North Ireland, United Kingdom.
   [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212, United States.
   [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212, United States.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   Queens University Belfast; Vanderbilt University; Vanderbilt University
RP Matthay, MA (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM michael.matthay@ucsf.edu
RI Ware, Lorraine/AAJ-9307-2021
OI Ware, Lorraine/0000-0002-9429-4702; McAuley, Daniel/0000-0002-3283-1947
FU NHBLI [R37 HL51856, U01 HL108713]; Courtney's Race for the Cure;
   Courtney Charneco Family; NIH [HL103836, HL126176]
FX This Review was supported by NHBLI R37 HL51856 and U01 HL108713 (MAM),
   as well as Courtney's Race for the Cure, The Courtney Charneco Family,
   NIH HL103836, and NIH HL126176 (LBW). We thank Andrew Manies for
   assistance with preparation of the manuscript and Diana Lim for her work
   on the figure.
CR Abraham E, 1999, CRIT CARE MED, V27, P1478, DOI 10.1097/00003246-199908000-00013
   Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55
   Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Beitler JR, 2016, CRIT CARE MED, V44, P91, DOI 10.1097/CCM.0000000000001355
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164
   BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927
   Blackwood B, 2014, AM J RESP CRIT CARE, V189, P886, DOI 10.1164/rccm.201309-1645PP
   Boutaud O, 2010, P NATL ACAD SCI USA, V107, P2699, DOI 10.1073/pnas.0910174107
   Boyle AJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0846-4
   Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166
   Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015
   Brower RG, 2004, NEW ENGL J MED, V351, P327
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87
   Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Chen W, 2015, CRIT CARE MED, V43, P801, DOI 10.1097/CCM.0000000000000789
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Festic E, 2017, CRIT CARE MED, V45, P798, DOI 10.1097/CCM.0000000000002284
   Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC
   Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
   Gainnier M, 2004, CRIT CARE MED, V32, P113, DOI 10.1097/01.CCM.0000104114.72614.BC
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043
   Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052
   Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448
   Gattinoni L, 2013, AM J RESP CRIT CARE, V188, P1286, DOI 10.1164/rccm.201308-1532CI
   Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585
   Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Guervilly C, 2017, INTENS CARE MED, V43, P408, DOI 10.1007/s00134-016-4653-4
   HALLMAN M, 1985, J PEDIATR-US, V106, P963, DOI 10.1016/S0022-3476(85)80253-5
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Hough CL, 2014, CLIN CHEST MED, V35, P781, DOI 10.1016/j.ccm.2014.08.014
   Huang DT, 2017, ANN AM THORAC SOC, V14, P124, DOI 10.1513/AnnalsATS.201608-629OT
   Iwashyna TJ, 2015, AM J RESP CRIT CARE, V192, P1045, DOI 10.1164/rccm.201411-2125CP
   Janz DR, 2015, CRIT CARE MED, V43, P534, DOI 10.1097/CCM.0000000000000718
   Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54
   Kallet RH, 2014, RESP CARE, V59, P1611, DOI 10.4187/respcare.02593
   Kangelaris KN, 2016, CRIT CARE MED, V44, P120, DOI 10.1097/CCM.0000000000001359
   Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330
   Levitt JE, 2013, CRIT CARE MED, V41, P1929, DOI 10.1097/CCM.0b013e31828a3d99
   Levitt JE, 2009, CHEST, V135, P936, DOI 10.1378/chest.08-2346
   Lipsky AM, 2013, STAT MED, V32, P3752, DOI 10.1002/sim.5807
   Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC
   Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z
   Luo L, 2017, CHEST, V151, P755, DOI 10.1016/j.chest.2016.09.004
   Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC
   Matthay MA, 2017, STEM CELLS, V35, P316, DOI 10.1002/stem.2551
   Matthay MA, 2016, CHEST, V150, P989, DOI 10.1016/j.chest.2016.05.013
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637
   Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159
   Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646
   Meyer NJ, 2017, LANCET RESP MED, V5, P512, DOI 10.1016/S2213-2600(17)30187-X
   Mrozek S, 2016, CHEST, V150, P998, DOI 10.1016/j.chest.2016.03.016
   MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0
   Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372
   Pelosi P, 2001, SEM RESP CRIT CARE M, V22, P259, DOI 10.1055/s-2001-15783
   Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435
   Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317
   Rubenfeld GD, 2015, AM J RESP CRIT CARE, V191, P255, DOI 10.1164/rccm.201408-1574CP
   Neto AS, 2016, LANCET RESP MED, V4, P882, DOI 10.1016/S2213-2600(16)30305-8
   SHAPIRO DL, 1985, PEDIATRICS, V76, P593
   Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015
   Shaver CM, 2014, CLIN CHEST MED, V35, P639, DOI 10.1016/j.ccm.2014.08.004
   Silversides JA, 2017, INTENS CARE MED, V43, P155, DOI 10.1007/s00134-016-4573-3
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   Spragg RG, 2004, NEW ENGL J MED, V351, P884, DOI 10.1056/NEJMoa033181
   Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
   Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614
   Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Vieillard-Baron A, 2000, AM J RESP CRIT CARE, V161, P1597
   Vincent JL, 2009, CRIT CARE MED, V37, P1874, DOI 10.1097/CCM.0b013e31819fff2c
   Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6
   Wang CY, 2014, INTENS CARE MED, V40, P388, DOI 10.1007/s00134-013-3186-3
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
   Warren MA, 2017, AM J RESP C IN PRESS
   Wheeler AP, 2006, NEW ENGL J MED, V354, P2213
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Wiedemann HP, 2000, JAMA-J AM MED ASSOC, V283, P1995
   Wiedemann HP, 2002, CRIT CARE MED, V30, P1
   Willson DF, 2015, CHEST, V148, P356, DOI 10.1378/chest.14-1139
   Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/s2213-2600(14)70291-7, 10.1016/S2213-2600(14)70291-7]
   Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015
   Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85
   Zeyed YF, 2012, AM J PHYSIOL-LUNG C, V303, pL550, DOI 10.1152/ajplung.00190.2012
NR 99
TC 180
Z9 193
U1 4
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-2600
J9 LANCET RESP MED
JI Lancet Resp. Med.
PD JUN
PY 2017
VL 5
IS 6
BP 524
EP 534
DI 10.1016/S2213-2600(17)30188-1
PG 11
WC Critical Care Medicine; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Respiratory System
GA EV9FR
UT WOS:000402091700023
PM 28664851
DA 2023-08-21
ER

PT J
AU Lamers, MM
   Haagmans, BL
AF Lamers, Mart M.
   Haagmans, Bart L.
TI SARS-CoV-2 pathogenesis
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID RESPIRATORY-DISTRESS-SYNDROME; CORONAVIRUS DISEASE 2019; PLASMACYTOID
   DENDRITIC CELLS; DIPEPTIDYL PEPTIDASE 4; ACUTE LUNG INJURY;
   TISSUE-FACTOR; COVID-19 INFECTIONS; FUNCTIONAL RECEPTOR;
   VIRAL-INFECTIONS; I INTERFERON
AB The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating pandemic. Although most people infected with SARS-CoV-2 develop a mild to moderate disease with virus replication restricted mainly to the upper airways, some progress to having a life-threatening pneumonia. In this Review, we explore recent clinical and experimental advances regarding SARS-CoV-2 pathophysiology and discuss potential mechanisms behind SARS-CoV-2-associated acute respiratory distress syndrome (ARDS), specifically focusing on new insights obtained using novel technologies such as single-cell omics, organoid infection models and CRISPR screens. We describe how SARS-CoV-2 may infect the lower respiratory tract and cause alveolar damage as a result of dysfunctional immune responses. We discuss how this may lead to the induction of a 'leaky state' of both the epithelium and the endothelium, promoting inflammation and coagulation, while an influx of immune cells leads to overexuberant inflammatory responses and immunopathology. Finally, we highlight how these findings may aid the development of new therapeutic interventions against COVID-19.
   In this Review, Lamers and Haagmans explore recent clinical and experimental advances in understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis, interactions with host cells and the involvement of the immune system in the development of severe disease. Specifically, they focus on mechanisms underlying the development of COVID-19-associated acute respiratory distress syndrome.
C1 [Lamers, Mart M.; Haagmans, Bart L.] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC
RP Haagmans, BL (corresponding author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
EM b.haagmans@erasmusmc.nl
RI Haagmans, Bart L/E-9791-2015
OI Haagmans, Bart L/0000-0001-6221-2015
CR ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130
   Ader F, 2022, LANCET INFECT DIS, V22, P209, DOI 10.1016/S1473-3099(21)00485-0
   Agrawal A, 2013, GERONTOLOGY, V59, P421, DOI 10.1159/000350536
   Ahn JH, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148517
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Arribas, 2021, NEJM EVID, DOI 10.1056/EVIDoa2100044
   Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261
   Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348
   Bailey AL, 2021, CELL, V184, P15, DOI 10.1016/j.cell.2020.12.003
   Bange Erin M, 2021, Res Sq, DOI 10.21203/rs.3.rs-162289/v1
   Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782
   Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340
   Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044
   Beumer J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25729-7
   Bhatnagar J, 2021, J INFECT DIS, V223, P752, DOI 10.1093/infdis/jiab039
   Blair RV, 2021, AM J PATHOL, V191, P274, DOI 10.1016/j.ajpath.2020.10.016
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9
   Bove PF, 2014, AM J RESP CELL MOL, V50, P767, DOI 10.1165/rcmb.2013-0071OC
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Camprubi-Rimblas M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.08
   Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Cardinal-Fernandez P, 2017, ANN AM THORAC SOC, V14, P844, DOI 10.1513/AnnalsATS.201609-728PS
   Carroll T, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1009914
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770
   Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325
   Chandra A, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237207
   Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen JY, 2020, CELL RES, V30, P708, DOI 10.1038/s41422-020-0369-7
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen YF, 2020, J MED VIROL, V92, P833, DOI 10.1002/jmv.25825
   Choi J, 2020, CELL STEM CELL, V27, P366, DOI 10.1016/j.stem.2020.06.020
   Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4
   Costa MFD, 2020, STEM CELL REP, V15, P1015, DOI 10.1016/j.stemcr.2020.09.006
   Creech CB, 2021, JAMA-J AM MED ASSOC, V325, P1318, DOI 10.1001/jama.2021.3199
   Daly James L, 2020, Science, V370, P861, DOI 10.1126/science.abd3072
   Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030
   De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156
   del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
   Delorey TM, 2021, NATURE, V595, P107, DOI 10.1038/s41586-021-03570-8
   Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497
   Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040
   Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10
   Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Feng E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030708
   Ferreira AC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00428-w
   Fielding BC, 2011, FUTURE MICROBIOL, V6, P153, DOI [10.2217/fmb.10.166, 10.2217/FMB.10.166]
   Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609
   Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R
   Georg P, 2022, CELL, V185, P493, DOI [10.1016/j.cel.2021.12.040, 10.1016/j.cell.2021.12.040]
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13
   Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730
   Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Halfmann PJ, 2022, NATURE, V603, P687, DOI 10.1038/s41586-022-04441-6
   Han LL, 2021, J MED VIROL, V93, P5376, DOI 10.1002/jmv.27050
   Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008
   Hewitson JP, 2020, J IMMUNOL, V204, P2949, DOI 10.4049/jimmunol.1900940
   Hoffmann M, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103255
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042
   Huang Jessie, 2020, Cell Stem Cell, V27, P962, DOI [10.1101/2020.06.30.175695, 10.1016/j.stem.2020.09.013]
   Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4
   Hulswit RJG, 2016, ADV VIRUS RES, V96, P29, DOI 10.1016/bs.aivir.2016.08.004
   Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12
   Iba T, 2020, J THROMB HAEMOST, V18, P2103, DOI 10.1111/jth.14975
   Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   JONES T, 2021, SCIENCE, V373
   Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368
   Kanegai CM, 2016, AM J RESP CELL MOL, V55, P613, DOI 10.1165/rcmb.2015-0387LE
   Karagiannidis C, 2021, LANCET RESP MED, V9, pE47, DOI 10.1016/S2213-2600(21)00101-6
   Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7
   Karki Rajendra, 2020, bioRxiv, DOI [10.1016/j.cell.2020.11.025, 10.1101/2020.10.29.361048]
   Katsura H, 2020, CELL STEM CELL, V27, P890, DOI 10.1016/j.stem.2020.10.005
   Katzenstein A L, 1976, Am J Pathol, V85, P209
   Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12
   Kayesh MEH, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13112302
   Kenawy HI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00215
   Khan M, 2021, CELL, V184, P5932, DOI 10.1016/j.cell.2021.10.027
   Khanmohammadi S, 2021, J MED VIROL, V93, P2735, DOI 10.1002/jmv.26826
   Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023
   Klimstra William B, 2020, bioRxiv, DOI 10.1101/2020.06.19.154930
   Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
   Kluge S, 2021, DTSCH ARZTEBL INT, V118, P1, DOI 10.3238/arztebl.m2021.0110
   Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226
   Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8
   Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lamers MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66815
   Lamers MM, 2021, EMBO J, V40, DOI 10.15252/embj.2020105912
   Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669
   Lamers MM., SARS COV 2 OMICRON E, DOI 10.1101/2022.01.19.476898
   Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050
   Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Little DR, 2019, P NATL ACAD SCI USA, V116, P20545, DOI 10.1073/pnas.1906663116
   Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20
   Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Mackman N, 2020, ARTERIOSCL THROM VAS, V40, P2033, DOI 10.1161/ATVBAHA.120.314514
   Mahajan S, 2021, AM J MED, V134, P812, DOI 10.1016/j.amjmed.2021.01.020
   Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061
   Marconi VC, 2021, LANCET RESP MED, V9, P1407, DOI 10.1016/S2213-2600(21)00331-3
   Galvan-Roman JM, 2021, J ALLERGY CLIN IMMUN, V147, P72, DOI 10.1016/j.jaci.2020.09.018
   Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832
   Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5
   Melms JC, 2021, NATURE, V595, P114, DOI 10.1038/s41586-021-03569-1
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Meyer NJ, 2021, LANCET, V398, P622, DOI 10.1016/S0140-6736(21)00439-6
   Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Mulay A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109055
   Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6
   Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]
   Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z
   Mykytyn AZ, 2021, ELIFE, V10, DOI 10.7554/eLife.64508
   Netea MG, 2020, CELL, V181, P969, DOI 10.1016/j.cell.2020.04.042
   Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x
   O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0
   Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453
   Osterrieder N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070779
   Ouwendijk WJD, 2021, J INFECT DIS, V223, P1512, DOI 10.1093/infdis/jiab050
   Owens AP, 2010, THROMB HAEMOSTASIS, V104, P432, DOI 10.1160/TH09-11-0771
   Page G, 2013, INT IMMUNOPHARMACOL, V17, P1176, DOI 10.1016/j.intimp.2013.06.004
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y
   Parasa S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11335
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9
   Pfizer, 2021, PFIZERS NOVEL
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0
   RANE CK, 2019, AM J PHYSIOL-LUNG C, V316
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rebendenne A., 2021, BIDIRECTIONAL GENOME, DOI 10.1101/2021.05.19.444823
   Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264
   Rendeiro AF, 2021, NATURE, V593, P564, DOI 10.1038/s41586-021-03475-6
   Rentsch CT, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n311
   Richard M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17367-2
   Robinot R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24521-x
   Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314
   Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300
   Salahudeen AA, 2020, NATURE, V588, P670, DOI 10.1038/s41586-020-3014-1
   Sampaio NG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92940-3
   Sang YQ, 2021, BLOOD REV, V46, DOI 10.1016/j.blre.2020.100733
   Sariol A, 2021, NAT IMMUNOL, V22, P801, DOI 10.1038/s41590-021-00962-w
   Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001
   Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481
   Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3
   Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x
   Swieringa F, 2018, RES PRACT THROMB HAE, V2, P450, DOI 10.1002/rth2.12107
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004
   Trimpert J, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108488
   Tsang TK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26709-7
   Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5
   V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6
   van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458
   van der Vaart J, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.049060
   Vanderheiden A, 2021, MBIO, V12, DOI 10.1128/mBio.02749-21
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Venet F, 2021, ANN NY ACAD SCI, V1499, P3, DOI 10.1111/nyas.14333
   Venet M., 2021, SARS COV 2 INFECT CE, DOI 10.1101/2021.09.01.21262969
   Vora SM, 2021, NAT REV IMMUNOL, V21, P694, DOI 10.1038/s41577-021-00588-x
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang DW, 2020, J COASTAL RES, P1, DOI 10.2112/JCR-SI109-001.1
   Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028
   Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163
   Wendisch D, 2021, CELL, V184, P6243, DOI 10.1016/j.cell.2021.11.033
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]
   Williamson EJ., 2020, NATURE, V584, P430, DOI [10.1101/2020.05.06.20092999, DOI 10.1101/2020.05.06.20092999]
   Wong LYR, 2022, NAT REV IMMUNOL, V22, P47, DOI 10.1038/s41577-021-00656-2
   Woolsey C, 2021, NAT IMMUNOL, V22, P86, DOI 10.1038/s41590-020-00835-8
   World Health Organization, 2003, CONS DOC EP SEV AC R
   Wu J, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108761
   Wu P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24482-1
   Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]
   Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628
   Youk J, 2020, CELL STEM CELL, V27, P905, DOI 10.1016/j.stem.2020.10.004
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang JH, 2021, CELL MOL IMMUNOL, V18, P1305, DOI 10.1038/s41423-021-00665-0
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114
   Zheng J, 2021, J INFECT DIS, V223, P785, DOI 10.1093/infdis/jiaa753
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou J, 2020, NAT MED, V26, P1077, DOI 10.1038/s41591-020-0912-6
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   Zhou P, 2020, NATURE, V579, P270, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Ziegler Carly G K, 2021, bioRxiv, DOI [10.1016/j.cell.2021.07.023, 10.1101/2021.02.20.431155]
   Zuo Yu, 2020, medRxiv, DOI 10.1101/2020.08.29.20184358
NR 231
TC 161
Z9 163
U1 40
U2 114
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD MAY
PY 2022
VL 20
IS 5
BP 270
EP 284
DI 10.1038/s41579-022-00713-0
EA MAR 2022
PG 15
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 0N1LD
UT WOS:000775742300001
PM 35354968
OA Bronze
DA 2023-08-21
ER

PT J
AU Herold, S
   Becker, C
   Ridge, KM
   Budinger, GRS
AF Herold, Susanne
   Becker, Christin
   Ridge, Karen M.
   Budinger, G. R. Scott
TI Influenza virus-induced lung injury: pathogenesis and implications for
   treatment
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID N-LINKED GLYCOSYLATION; RECEPTOR-BINDING SPECIFICITY; ALVEOLAR
   EPITHELIAL-CELLS; COLONY-STIMULATING FACTOR; AIRWAY STEM-CELLS; A VIRUS;
   PANDEMIC INFLUENZA; DENDRITIC CELLS; T-CELLS; NEURAMINIDASE INHIBITORS
AB The influenza viruses are some of the Most important human pathogens, causing substantial seasonal and pandemic morbidity and mortality. In humans, infection of the lower respiratory tract of can result in flooding of the alveolar compartment, development of acute respiratory distress syndrome and death from respiratory failure. Influenza-mediated damage of the airway, alveolar epithelium and alveolar endothelium results from a combination of: 1) intrinsic viral pathogenicity, attributable to its tropism for host airway and alveolar epithelial cells; and 2) a robust host innate immune response, which, while contributing to viral clearance, can worsen the severity of lung injury. In this review, we summarise the molecular events at the virus host interface during influenza virus infection, highlighting some of the important cellular responses. We discuss immune-mediated viral clearance, the mechanisms promoting or perpetuating lung injury, lung regeneration after influenza-induced injury, and recent advances in influenza prevention and therapy.
C1 [Herold, Susanne; Becker, Christin] Univ Giessen, Univ Giessen & Marburg Lung Ctr, Dept Internal Med 2, D-35390 Giessen, Germany.
   [Ridge, Karen M.; Budinger, G. R. Scott] Northwestern Univ, Pulm & Crit Care Med, Chicago, IL 60611, United States.
C3 Justus Liebig University Giessen; Northwestern University
RP Herold, S (corresponding author), Univ Giessen & Marburg Lung Ctr, Dept Internal Med 2, Klin Str 33, D-35392 Giessen, Germany.
EM susanne.herold@innere.med.uni-giessen.de
OI Peteranderl, Christin/0000-0003-3799-8268; Herold,
   Susanne/0000-0001-6343-0911
FU NHLBI NIH HHS [R01 HL124664, P01 HL071643] Funding Source: Medline
CR Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004
   Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106
   Anikina AG, 2014, B EXP BIOL MED+, V156, P833, DOI 10.1007/s10517-014-2463-7
   [Anonymous], 2014, Wkly Epidemiol Rec, V89, P93
   Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10
   Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710
   Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449
   Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918
   Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609
   Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995
   Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000
   Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229
   Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018
   Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058
   Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06
   Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166
   Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11
   Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013
   Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020
   Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918
   Cakarova L, 2009, AM J RESP CRIT CARE, V180, P521, DOI 10.1164/rccm.200812-1837OC
   Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08
   Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612
   Capelozzi VL, 2010, CLINICS, V65, P1229, DOI 10.1590/S1807-59322010001200003
   Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136
   Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797
   Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10
   Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262
   Cortes Garcia M, 2012, J INFECTION, V64, P218
   Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407
   Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526
   Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864
   Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7
   De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014
   Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930
   Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538
   Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Enserink M, 2005, SCIENCE, V309, P1976
   Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/201001-0037OC, 10.1164/rccm.201001-0037OC]
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006
   Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365
   Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014
   Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC
   Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137
   Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691
   Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10
   Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448
   Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774
   Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659
   Herold S, 2014, AM J RESP CRIT CARE, V189, P609, DOI 10.1164/rccm.201311-2041LE
   Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065
   Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC
   Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201
   Hillaire MLB, 2013, J INNATE IMMUN, V5, P197, DOI 10.1159/000346374
   Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595
   Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581
   Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850
   Hui DSC, 2013, INFLUENZA OTHER RESP, V7, P52, DOI 10.1111/irv.12171
   Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ivanov S, 2013, J VIROL, V87, P6911, DOI 10.1128/JVI.02943-12
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695
   Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632
   Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC
   Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]
   Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051
   Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541
   KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989
   Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667
   Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07
   Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004
   Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006
   Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204
   Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951
   Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016
   Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791
   Kourtis AP, 2014, NEW ENGL J MED, V371, P1077, DOI [10.1056/NEJMra1213566, 10.1056/NEJMc1408436]
   Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025
   Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013
   Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001
   Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   Leeman KT, 2014, CURR TOP DEV BIOL, V107, P207, DOI 10.1016/B978-0-12-416022-4.00008-1
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617
   Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005
   Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673
   Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562
   Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002
   Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10
   Ljungman P, 2011, HAEMATOL-HEMATOL J, V96, P1231, DOI 10.3324/haematol.2011.041913
   Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012
   Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636
   Ludwig S, 2014, INT J MED MICROBIOL, V304, P894, DOI 10.1016/j.ijmm.2014.08.016
   Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI [10.1056/NEJMoa1401480, 10.1056/NEJMc1412050]
   Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570
   Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238
   Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC
   MASON RJ, 1994, AM J RESP CELL MOL, V11, P561, DOI 10.1165/ajrcmb.11.5.7524567
   Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x
   McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014
   McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314
   McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711
   Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906
   Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33
   Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170
   Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740
   Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315
   Moss RB, 2012, J INFECT DIS, V206, P1844, DOI 10.1093/infdis/jis622
   Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC
   Ortiz JR, 2013, AM J RESP CRIT CARE, V188, P710, DOI 10.1164/rccm.201212-2341OC
   Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196
   Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m
   Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200
   Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Radigan KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035788
   Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Reading PC, 2007, ADV EXP MED BIOL, V598, P279
   Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166
   Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003
   Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003
   ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769
   Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000
   Santesso N, 2013, INFLUENZA OTHER RESP, V7, P76, DOI 10.1111/irv.12085
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8
   Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
   Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054
   Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350
   Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011
   Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001
   Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929
   Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765
   Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844
   Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06
   Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13
   Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294
   Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295
   Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618
   Taubenberger J, 2006, P AM PHILOS SOC, V150, P1
   Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230
   Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006
   Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057
   Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134
   Topham DJ, 1997, J IMMUNOL, V159, P5197
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848
   Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212
   Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005
   Uhlendorff J, 2009, ARCH VIROL, V154, P945, DOI 10.1007/s00705-009-0393-x
   Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139
   Uyeki TM, 2014, NEW ENGL J MED, V370, P789, DOI 10.1056/NEJMp1400034
   van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248
   van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949
   Ventetuolo CE, 2014, AM J RESP CRIT CARE, V190, P497, DOI 10.1164/rccm.201404-0736CI
   Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07
   Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090
   Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106
   Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879
   Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000
   Worobey M, 2014, NATURE, V508, P254, DOI 10.1038/nature13016
   Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165
   Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713
   Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40
   Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
   Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903
NR 200
TC 262
Z9 271
U1 9
U2 61
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD MAY
PY 2015
VL 45
IS 5
BP 1463
EP 1478
DI 10.1183/09031936.00186214
PG 16
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA CH6KI
UT WOS:000354145100030
PM 25792631
OA Bronze
DA 2023-08-21
ER

PT J
AU Otifi, HM
   Adiga, BK
AF Otifi, Hassan M.
   Adiga, Balkur K.
TI Endothelial Dysfunction in Covid-19 Infection
SO AMERICAN JOURNAL OF THE MEDICAL SCIENCES
LA English
DT Review
DE COVID-19/SARS-CoV-2/Coronavirus; endothelial dysfunction; ACE/ACE2; NO; endotheliitis; Hypercoagulopathy 
ID CORONAVIRUS DISEASE 2019; BARRIER DYSFUNCTION; PNEUMONIA; SYSTEM; CELLS
AB COVID-19 is an evolving systemic inflammatory pandemic disease, predominantly affecting the respiratory system. Associated cardiovascular comorbid conditions result in severe to critical illness with mortality up to 14.8 % in octogenarians. The role of endothelial dysfunction in its pathogenesis has been proposed with laboratory and autopsy data, though initially it was thought of as only acute respiratory distress syndrome (ARDS). The current study on endothelial dysfunction in SARS CoV-2 infection highlights its pathophysiology through the effects of direct viral-induced endothelial injury, uncontrolled immune & inflammatory response, imbalanced coagulation homeostasis, and their interactions resulting in a vicious cycle aggravating the disease process. This review may provide further light on proper laboratory tests and therapeutic implications needed for better management of patients. The main objective of the study is to understand the pathophysiology of COVID-19 with respect to the role of endothelium so that more additional relevant treatment may be incorporated in the management protocol.
C1 [Otifi, Hassan M.; Adiga, Balkur K.] King Khalid Univ, Coll Med, Dept Pathol, POB 641, Abha, Saudi Arabia.
C3 King Khalid University
RP Otifi, HM (corresponding author), King Khalid Univ, Coll Med, Dept Pathol, POB 641, Abha, Saudi Arabia.
EM hotifi@kku.edu.sa
RI Otifi, Hassan M/GOV-7065-2022
OI Otifi, Hassan M/0000-0002-1735-6041
FU King Khalid University, Abha, Saudi Arabia [GRP-218-40]
FX This work was supported by the Deanship of Scientific Research at King
   Khalid University, Abha, Saudi Arabia, through the General Research
   Project under grant number (GRP-218-40).
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9
   Boudhabhay I, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.680567
   Buja LM, 2020, CARDIOVASC PATHOL, V48, DOI 10.1016/j.carpath.2020.107233
   Calabretta E, 2021, BRIT J HAEMATOL, V193, P43, DOI 10.1111/bjh.17240
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Chakrabarti S., 2016, FOOD SCI HUM WELL, V5, P1, DOI [10.1016/j.fshw.2015.11.004, DOI 10.1016/J.FSHW.2015.11.004]
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Copin MC, 2020, INTENS CARE MED, V46, P1124, DOI 10.1007/s00134-020-06057-8
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415
   Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014
   Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4
   Fogarty H, 2020, BRIT J HAEMATOL, V189, P1044, DOI [10.1111/bjh.16749, 10.1111/bjh.16791]
   Fu YJ, 2020, VIROL SIN, V35, P266, DOI 10.1007/s12250-020-00207-4
   Gavriilaki E, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01078-6
   Gupta MD, 2020, INDIAN HEART J, V72, P1, DOI 10.1016/j.ihj.2020.03.006
   He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Keller TT, 2003, CARDIOVASC RES, V60, P40, DOI 10.1016/S0008-6363(03)00354-7
   Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
   Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107
   Loomans CJM, 2006, ARTERIOSCL THROM VAS, V26, P1760, DOI 10.1161/01.ATV.0000229243.49320.c9
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450
   Mastellos DC, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108598
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Miranda M, 2016, AM J PHYSIOL-HEART C, V311, pH24, DOI 10.1152/ajpheart.00034.2016
   N_agele MP, 2020, ATHEROSCLEROSIS
   Ng N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10102188
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331
   Organization WH, 2020, COR DIS COVID 19
   Pober JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01907
   Pons S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03062-7
   Risitano AM, 2020, NAT REV IMMUNOL, V20, P343, DOI 10.1038/s41577-020-0320-7
   Sardu C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051417
   Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907
   SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876
   Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Tale S, 2020, QJM-INT J MED, V113, P837, DOI 10.1093/qjmed/hcaa255
   Tang DL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008536
   Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Verdecchia P, 2020, EUR J INTERN MED, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019
   Wong SW, 2021, ANN ACAD MED SINGAP, V50, P425, DOI 10.47102/annals-acadmedsg.202175
   World Health Organization, 2022, TRACK SARS COV 2 VAR
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou BY, 2020, PATHOG DIS, V78, DOI 10.1093/femspd/ftaa026
NR 63
TC 36
Z9 37
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9629
EI 1538-2990
J9 AM J MED SCI
JI Am. J. Med. Sci.
PD APR
PY 2022
VL 363
IS 4
BP 281
EP 287
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 2R5IU
UT WOS:000821146500006
PM 35093394
OA Green Published, Bronze
DA 2023-08-21
ER

EF